Naveed Sattar
#51,412
Most Influential Person Now
Scottish medical researcher
Naveed Sattar's AcademicInfluence.com Rankings
Naveed Sattarphilosophy Degrees
Philosophy
#1939
World Rank
#3409
Historical Rank
Logic
#368
World Rank
#713
Historical Rank
Download Badge
Philosophy
Why Is Naveed Sattar Influential?
(Suggest an Edit or Addition)According to Wikipedia, Naveed Amjid Sattar is a Scottish medical researcher and Professor of Metabolic Medicine at the Institute of Cardiovascular & Medical Sciences at the University of Glasgow, as well as an Honorary Consultant in Metabolic Medicine at the Glasgow Royal Infirmary. He was described by the BBC as "a leading expert in diabetes and cardio-vascular disease research". He has been an ISI Highly Cited Researcher since 2014. In 2016, he was elected a fellow of the Academy of Medical Sciences. He is also a Fellow of the Royal College of Pathologists, the Royal College of Physicians and Surgeons of Glasgow, and the Royal Society of Edinburgh.
Naveed Sattar's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetic studies of body mass index yield new insights for obesity biology (2015) (3549)
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. (2010) (1978)
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. (2020) (1960)
- [2016 European Guidelines on cardiovascular disease prevention in clinical practice]. (2016) (1881)
- Diabetes mellitus, fasting glucose, and risk of cause-specific death. (2011) (1874)
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. (2020) (1835)
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials (2010) (1770)
- Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study (2003) (1584)
- Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents (2016) (1582)
- Major lipids, apolipoproteins, and risk of vascular disease. (2009) (1563)
- Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials (2009) (1339)
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (2009) (1304)
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction. (2021) (1081)
- Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. (2011) (1065)
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial (2017) (1038)
- Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps (2018) (1028)
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. (2021) (961)
- Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. (2003) (956)
- C-reactive protein, fibrinogen, and cardiovascular disease prediction. (2012) (952)
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2012) (904)
- Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study (2001) (896)
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update (2016) (865)
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis (2012) (864)
- Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) (2001) (859)
- Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial (2004) (802)
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes (2017) (787)
- Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? (2002) (765)
- Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways (2012) (758)
- A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance (2012) (756)
- C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. (2002) (754)
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes (2018) (732)
- Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies (2018) (727)
- Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies (2018) (727)
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. (2019) (724)
- Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. (2010) (642)
- IL-33 reduces the development of atherosclerosis (2008) (632)
- Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. (2002) (632)
- Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. (2011) (589)
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study (2020) (589)
- Low grade chronic inflammation in women with polycystic ovarian syndrome. (2001) (585)
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (2015) (559)
- Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data (2014) (547)
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study (2020) (544)
- Association of Cardiometabolic Multimorbidity With Mortality. (2015) (535)
- Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. (2002) (534)
- The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study (2015) (532)
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. (2016) (529)
- Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. (2015) (520)
- Rare and low-frequency coding variants alter human adult height (2016) (511)
- Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies (2008) (499)
- Association of Maternal Weight Gain in Pregnancy With Offspring Obesity and Metabolic and Vascular Traits in Childhood (2010) (476)
- Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals (2012) (459)
- Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. (2010) (457)
- Lipid-related markers and cardiovascular disease prediction. (2012) (457)
- Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. (2015) (445)
- Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. (2020) (440)
- Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease (2016) (434)
- Exome-wide association study of plasma lipids in >300,000 individuals (2017) (428)
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. (2016) (417)
- Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis (2006) (412)
- Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. (2019) (403)
- Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. (2015) (401)
- Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians (2001) (380)
- Vitamin D concentrations and COVID-19 infection in UK Biobank (2020) (379)
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
- Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. (2004) (376)
- Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. (2002) (368)
- Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study (2018) (364)
- Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants (2018) (362)
- B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies (2009) (361)
- Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study (2017) (355)
- Metabolic Syndrome and Incident Diabetes (2008) (347)
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis (2018) (340)
- Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting (2017) (338)
- The changing face of diabetes complications. (2016) (332)
- Lipoprotein Subfraction Concentrations in Preeclampsia: Pathogenic Parallels to Atherosclerosis (1997) (326)
- Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age: The Avon Longitudinal Study of Parents and Children (2012) (324)
- Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants (2020) (323)
- Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. (2009) (318)
- A Novel Anti-Inflammatory Role for Simvastatin in Inflammatory Arthritis 1 (2003) (317)
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (2020) (310)
- Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. (2012) (310)
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. (2016) (309)
- Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. (2008) (302)
- Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data (2010) (301)
- Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study (2010) (296)
- Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes (2017) (294)
- Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions (2009) (291)
- Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure (2020) (288)
- Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia (2004) (286)
- Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital (2005) (285)
- Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis. (2016) (285)
- Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension (2010) (285)
- Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? (2004) (283)
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study (2017) (283)
- Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice (2010) (280)
- Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank (2020) (279)
- Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study (2012) (278)
- Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK (2006) (271)
- Gamma-Glutamyltransferase Is Associated With Incident Vascular Events Independently of Alcohol Intake: Analysis of the British Women’s Heart and Health Study and Meta-Analysis (2007) (265)
- Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. (2000) (263)
- SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? (2016) (260)
- Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. (2011) (257)
- Role for TNF in atherosclerosis? Lessons from autoimmune disease (2009) (256)
- Pravastatin and cognitive function in the elderly. Results of the PROSPER study (2009) (255)
- Measurement of the Systemic Inflammatory Response Predicts Cancer-Specific and Non-Cancer Survival in Patients With Cancer (2001) (248)
- Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels (2018) (246)
- Inflammation and ischaemic stroke (2007) (245)
- Do men develop type 2 diabetes at lower body mass indices than women? (2011) (245)
- Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study (2013) (244)
- Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome (2003) (242)
- Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review (2012) (239)
- Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis (2017) (239)
- Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age (2014) (238)
- Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension (2016) (234)
- GDF15 mediates the effects of metformin on body weight and energy balance (2019) (233)
- Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. (2005) (232)
- Glomerular hyperfiltration: a new marker of metabolic risk. (2007) (229)
- Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort (2009) (229)
- Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring (2010) (228)
- Obesity in pregnancy: prevalence and metabolic consequences. (2010) (223)
- Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. (2018) (221)
- Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. (2012) (220)
- Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. (1997) (219)
- Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes. (2016) (218)
- Association Between Genetic Variants on Chromosome 15q25 Locus and Objective Measures of Tobacco Exposure (2012) (215)
- Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. (2017) (214)
- CVD risk factors and ethnicity--a homogeneous relationship? (2006) (210)
- Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins (2014) (207)
- Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland (2020) (207)
- Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease (2017) (204)
- Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. (2003) (203)
- Type 2 diabetes and cardiovascular disease in South Asians. (2011) (203)
- Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the Avon Longitudinal Study of Parents and Children (ALSPAC)1234 (2011) (202)
- Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. (2007) (202)
- Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study (2021) (201)
- Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. (1999) (201)
- SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. (2021) (200)
- Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. (2002) (199)
- Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm (2013) (199)
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. (2021) (196)
- Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery. (2018) (196)
- Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure underpinning obesity (2017) (193)
- A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function (2013) (193)
- Insight into the nature of the CRP-coronary event association using Mendelian randomization. (2006) (191)
- Classic and Novel Risk Factor Parameters in Women With a History of Preeclampsia (2003) (190)
- Glycated hemoglobin measurement and prediction of cardiovascular disease. (2014) (189)
- Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants (2020) (188)
- Smooth Muscle Enriched Long Noncoding RNA (SMILR) Regulates Cell Proliferation (2016) (186)
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. (2021) (182)
- Socio-economic status is associated with epigenetic differences in the pSoBid cohort. (2012) (181)
- Preeclampsia and Gestational Hypertension Are Associated With Childhood Blood Pressure Independently of Family Adiposity Measures: The Avon Longitudinal Study of Parents and Children (2010) (181)
- Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism (2017) (180)
- High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants (2017) (180)
- Leptin and coronary heart disease: prospective study and systematic review. (2009) (180)
- Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women’s Heart Health Study (2011) (180)
- Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease (2017) (179)
- Non-alcoholic fatty liver disease (2014) (179)
- Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters (2001) (178)
- Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study (2015) (174)
- Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. (2012) (174)
- Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies (1991) (173)
- Maternal adiposity—a determinant of perinatal and offspring outcomes? (2012) (171)
- Obesity—time to wake up (2006) (170)
- Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? (2013) (169)
- The Relationship Between Metabolic Risk Factors and Incident Cardiovascular Disease in Europeans, South Asians, and African Caribbeans (2013) (168)
- Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. (2007) (167)
- Paradoxical Elevation in Adiponectin Concentrations in Women With Preeclampsia (2003) (166)
- ABC of Obesity (2007) (166)
- A Genome-Wide Association Study Reveals Variants in ARL15 that Influence Adiponectin Levels (2009) (164)
- Ethnic-Specific Obesity Cutoffs for Diabetes Risk: Cross-sectional Study of 490,288 UK Biobank Participants (2014) (164)
- Early Emergence of Ethnic Differences in Type 2 Diabetes Precursors in the UK: The Child Heart and Health Study in England (CHASE Study) (2010) (163)
- Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. (2015) (162)
- Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. (2007) (161)
- Effect of CLA supplementation on immune function in young healthy volunteers (2005) (161)
- Revisiting the links between glycaemia, diabetes and cardiovascular disease (2013) (161)
- A Novel Anti-Inflammatory Role for Simvastatin in Inflammatory Arthritis (2003) (160)
- First-Trimester Prediction of Gestational Diabetes Mellitus: Examining the Potential of Combining Maternal Characteristics and Laboratory Measures (2010) (159)
- Assessment of obesity and its clinical implications (2006) (157)
- Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults (2019) (156)
- Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. (2004) (156)
- The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (2007) (155)
- Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF) (2020) (155)
- Implementation of proteomic biomarkers: making it work (2012) (155)
- The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. (1998) (155)
- Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies. (2016) (154)
- Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. (2014) (153)
- Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study (2017) (153)
- Type 2 diabetes as a disease of ectopic fat? (2014) (153)
- Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children. (2010) (151)
- Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase (2016) (151)
- The Trans-Ancestral Genomic Architecture of Glycemic Traits (2020) (151)
- Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? (2009) (150)
- Increasing requests for vitamin D measurement: costly, confusing, and without credibility (2012) (150)
- Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits (2017) (149)
- Microvascular dysfunction: a link between pre‐eclampsia and maternal coronary heart disease (2003) (148)
- Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels (2016) (147)
- Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre‐eclampsia (1996) (147)
- Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses. (2005) (146)
- Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation (2011) (145)
- Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks: Findings From the Swedish National Diabetes Registry (2019) (145)
- The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors (2017) (144)
- Directional dominance on stature and cognition in diverse human populations (2015) (144)
- Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts (2019) (144)
- Comparison of the Associations of Apolipoprotein B and Non–High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study (2004) (143)
- Cannabis use and risk of schizophrenia: a Mendelian randomization study (2016) (142)
- Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications (2015) (142)
- Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. (2005) (141)
- Myocardial Hemorrhage After Acute Reperfused ST-Segment–Elevation Myocardial Infarction (2016) (141)
- Developing a complex intervention for diet and activity behaviour change in obese pregnant women (the UPBEAT trial); assessment of behavioural change and process evaluation in a pilot randomised controlled trial (2013) (140)
- Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. (2012) (140)
- A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals (2019) (139)
- Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? (2008) (138)
- Comparison of the Associations of Apolipoprotein B and Low-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in the Insulin Resistance Atherosclerosis Study (IRAS) (2003) (137)
- Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. (2013) (136)
- Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes. (2017) (135)
- Multiethnic Meta-Analysis of Genome-Wide Association Studies in >100 000 Subjects Identifies 23 Fibrinogen-Associated Loci but No Strong Evidence of a Causal Association Between Circulating Fibrinogen and Cardiovascular Disease (2013) (133)
- First-Trimester Circulating 25-Hydroxyvitamin D Levels and Development of Gestational Diabetes Mellitus (2011) (132)
- The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent (2018) (132)
- Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology (1998) (131)
- Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children (2011) (131)
- Hypertensive Disorders of Pregnancy and Cardiometabolic Health in Adolescent Offspring (2013) (130)
- C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) (2007) (130)
- Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study (2013) (130)
- Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. (2006) (130)
- Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease (2018) (130)
- The association between physical activity and risk of mortality is modulated by grip strength and cardiorespiratory fitness: evidence from 498 135 UK-Biobank participants (2016) (130)
- Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs (2012) (130)
- The power of genetic diversity in genome-wide association studies of lipids (2021) (129)
- Association Between BMI Measured Within a Year After Diagnosis of Type 2 Diabetes and Mortality (2013) (129)
- Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. (2010) (128)
- Effect of the inflammatory response on trace element and vitamin status (2000) (128)
- Accelerated Telomere Attrition Is Associated with Relative Household Income, Diet and Inflammation in the pSoBid Cohort (2011) (127)
- Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? (2017) (126)
- The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials (2015) (123)
- Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology* (2019) (122)
- Ischemia and No Obstructive Coronary Artery Disease (2019) (121)
- Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data. (2016) (121)
- Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions (2005) (121)
- Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions (2012) (120)
- Physical activity, obesity and cardiometabolic risk factors in 9- to 10-year-old UK children of white European, South Asian and black African-Caribbean origin: the Child Heart And health Study in England (CHASE) (2010) (120)
- Pathophysiology of LV Remodeling in Survivors of STEMI (2015) (120)
- Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study (2007) (120)
- Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach. (2009) (120)
- Obesity Is a Risk Factor for Severe COVID-19 Infection (2020) (120)
- Understanding the mechanisms of reversal of type 2 diabetes. (2019) (119)
- Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial (2018) (119)
- Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study. (2007) (117)
- Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity (2017) (117)
- Leptin levels in pregnancy, marker for fat accumulation and mobilization? (1998) (117)
- Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. (2014) (117)
- Childhood obesity and vascular phenotypes: a population study. (2012) (117)
- Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease (2016) (116)
- Defining Obesity Cut-Off Points for Migrant South Asians (2011) (115)
- Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease (2019) (115)
- Maternal docosahexaenoic acid supplementation and fetal accretion (2003) (114)
- Cardiometabolic aspects of the polycystic ovary syndrome. (2012) (114)
- Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo‐controlled trial (2006) (114)
- Cardiac Troponin T and Troponin I in the General Population (2019) (113)
- Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups (2016) (113)
- The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase. (2005) (113)
- Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index (2011) (113)
- Statins are diabetogenic--myth or reality? (2012) (113)
- An assessment by the Statin Diabetes Safety Task Force: 2014 update. (2014) (112)
- Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis (2015) (112)
- Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors (2015) (112)
- Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions (2017) (110)
- Statins and the risk of new-onset diabetes: a review of recent evidence (2011) (109)
- Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events? (2009) (109)
- Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study (2019) (109)
- Antenatal Waist Circumference and Hypertension Risk (2001) (108)
- A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow‐up in a routine diabetes clinic (2006) (108)
- Fat Oxidation, Fitness and Skeletal Muscle Expression of Oxidative/Lipid Metabolism Genes in South Asians: Implications for Insulin Resistance? (2010) (107)
- Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. (2007) (107)
- External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? (2013) (107)
- Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? (1998) (106)
- Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial (2019) (106)
- An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy (2015) (106)
- Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland (2012) (106)
- Alkaline Phosphatase, Serum Phosphate, and Incident Cardiovascular Disease and Total Mortality in Older Men (2013) (105)
- Cerebral Microbleeds Are Predictive of Mortality in the Elderly (2011) (105)
- Associations of indices of adiposity with atherogenic lipoprotein subfractions (1998) (104)
- Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms (2010) (104)
- Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST‐Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical Implications (2016) (103)
- Association of Genetic Loci With Glucose Levels in Childhood and Adolescence (2011) (103)
- Inverse Association Between Birth Weight and C-Reactive Protein Concentrations in the MIDSPAN Family Study (2004) (103)
- Vitamin D and COVID-19 infection and mortality in UK Biobank (2020) (103)
- Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? (2011) (103)
- Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England (2021) (103)
- Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study (2011) (102)
- The Use of Blood Biomarkers to Predict Poor Outcome After Acute Transient Ischemic Attack or Ischemic Stroke (2012) (102)
- Plasmacytoid Dendritic Cells Play a Key Role in Promoting Atherosclerosis in Apolipoprotein E–Deficient Mice (2012) (102)
- Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction. (1999) (101)
- Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE—Southall And Brent REvisited) (2013) (101)
- Circulating interleukin‐6 concentration and cognitive decline in old age: the PROSPER study (2013) (100)
- Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies (2011) (100)
- Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma (2008) (99)
- Obesity and reproduction (2006) (99)
- The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice. (2014) (99)
- 1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA) (2019) (98)
- Reduced Incidence of Lower-Extremity Amputations in People With Diabetes in Scotland (2012) (98)
- Increasing physical activity in stroke survivors using STARFISH, an interactive mobile phone application: a pilot study (2016) (98)
- Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. (2010) (98)
- Strikingly Low Circulating CRP Concentrations in Ultramarathon Runners Independent of Markers of Adiposity: How Low Can You Go? (2003) (96)
- Score Based on Hypoalbuminemia and Elevated C-Reactive Protein Predicts Survival in Patients With Advanced Gastrointestinal Cancer (2004) (95)
- Metabolite Profiling and Cardiovascular Event RiskCLINICAL PERSPECTIVE (2015) (94)
- Waist-to-height ratio and cardiometabolic risk factors in adolescence: findings from a prospective birth cohort (2013) (93)
- Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. (2007) (93)
- Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus (2018) (93)
- Changes in Ponderal Index and Body Mass Index across Childhood and Their Associations with Fat Mass and Cardiovascular Risk Factors at Age 15 (2010) (93)
- A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease (2016) (92)
- Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes (1999) (91)
- The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. (2011) (91)
- Customised and Noncustomised Birth Weight Centiles and Prediction of Stillbirth and Infant Mortality and Morbidity: A Cohort Study of 979,912 Term Singleton Pregnancies in Scotland (2017) (91)
- Insulin Resistance and Truncal Obesity as Important Determinants of the Greater Incidence of Diabetes in Indian Asians and African Caribbeans Compared With Europeans (2013) (91)
- Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies. (2018) (91)
- Reverse Causality in Cardiovascular Epidemiological Research: More Common Than Imagined? (2017) (90)
- Allopurinol Use Yields Potentially Beneficial Effects on Inflammatory Indices in Those With Recent Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial (2008) (90)
- Impact of maternal obesity on perinatal and childhood outcomes. (2015) (89)
- Effect of weight loss and the inflammatory response on leptin concentrations in gastrointestinal cancer patients. (1998) (89)
- A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial (2014) (88)
- Management of obesity: summary of SIGN guideline (2010) (88)
- Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation (2020) (88)
- Leptin Predicts Diabetes but Not Cardiovascular Disease (2009) (88)
- Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls (2020) (88)
- The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial (2016) (87)
- Associations of mutually exclusive categories of physical activity and sedentary time with markers of cardiometabolic health in English adults: a cross-sectional analysis of the Health Survey for England (2015) (86)
- Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. (2004) (85)
- A Prospective Analysis of Elevated Fasting Glucose Levels and Cognitive Function in Older People (2010) (85)
- Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. (2015) (85)
- Retinal Arteriolar Tortuosity and Cardiovascular Risk Factors in a Multi-Ethnic Population Study of 10-Year-Old Children; the Child Heart and Health Study in England (CHASE) (2011) (85)
- Ethnicity and Outcomes from COVID-19: The ISARIC CCP-UK Prospective Observational Cohort Study of Hospitalised Patients (2020) (84)
- Relationship of carotenoid and vitamins A and E with the acute inflammatory response in acute pancreatitis (2000) (84)
- Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. (2005) (84)
- Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis (2016) (83)
- Factors Critical to Iontophoretic Assessment of Vascular Reactivity: Implications for Clinical Studies of Endothelial Dysfunction (2002) (83)
- Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial (2021) (83)
- Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission (2017) (82)
- Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss. (2019) (82)
- Associations Between Dietary Fiber and Inflammation, Hepatic Function, and Risk of Type 2 Diabetes in Older Men (2009) (82)
- Infant adiposity following a randomised controlled trial of a behavioural intervention in obese pregnancy (2017) (82)
- Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence (2009) (81)
- High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? (2011) (81)
- Ethnicity-specific obesity cut-points in the development of Type 2 diabetes – a prospective study including three ethnic groups in the United Kingdom (2014) (81)
- Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk (2020) (81)
- Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. (2013) (80)
- Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis (2016) (80)
- Elimination of Electrically Induced Iontophoretic Artefacts: Implications for Non-Invasive Assessment of Peripheral Microvascular Function (2002) (80)
- Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses (2021) (79)
- Vascular cell adhesion molecule‐1: a viable therapeutic target for atherosclerosis? (2007) (79)
- Secretory Phospholipase A2-IIA and Cardiovascular Disease (2013) (78)
- Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease (2019) (78)
- Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. (2011) (78)
- Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort. (2018) (78)
- Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies (2018) (78)
- N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. (2011) (78)
- Depot‐specific steroidogenic gene transcription in human adipose tissue (2008) (78)
- Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study (2020) (78)
- Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies (2018) (78)
- Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. (2017) (77)
- Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus (2019) (77)
- Novel Diabetes Drugs and the Cardiovascular Specialist. (2017) (77)
- Elevated Parathyroid Hormone, But Not Vitamin D Deficiency, Is Associated With Increased Risk of Heart Failure in Older Men With and Without Cardiovascular Disease (2014) (76)
- Metabolic profiling of gestational diabetes in obese women during pregnancy (2017) (76)
- Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study (2017) (76)
- Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial (2019) (75)
- Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60-64 years in the 1946 British birth cohort study: an epidemiological study. (2014) (75)
- A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. (2016) (75)
- Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis (2008) (75)
- Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013 (2016) (75)
- Associations of Gestational Diabetes, Existing Diabetes, and Glycosuria With Offspring Obesity and Cardiometabolic Outcomes (2011) (74)
- Lung Function and Risk of Type 2 Diabetes and Fatal and Nonfatal Major Coronary Heart Disease Events: Possible Associations With Inflammation (2010) (74)
- Neutrophil activation in pregnancy‐induced hypertension (1990) (74)
- Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose co-transporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial. (2020) (74)
- Circulating Interleukin-10 and Risk of Cardiovascular Events: A Prospective Study in the Elderly at Risk (2011) (74)
- Do pregnancy complications and CVD share common antecedents? (2004) (74)
- BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank (2020) (73)
- Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women (2010) (73)
- Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes. (2010) (73)
- A Longitudinal Study of the Relationships between Haemostatic, Lipid, and Oestradiol Changes during Normal Human Pregnancy (1999) (73)
- The obesity paradox in men with coronary heart disease and heart failure: The role of muscle mass and leptin (2014) (73)
- Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data (2018) (72)
- Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci (2019) (72)
- Adiponectin in childhood. (2008) (72)
- Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men (2015) (71)
- Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) (2012) (71)
- Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions (2019) (71)
- Low Triglyceride, Not Low Cholesterol Concentration, Independently Predicts Poor Outcome following Acute Stroke (2003) (70)
- Serum Chloride Is an Independent Predictor of Mortality in Hypertensive Patients (2013) (69)
- A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome. (2002) (69)
- Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme (2013) (69)
- The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: Significance of Pregnancy Associated Activated Protein C Resistance (2001) (69)
- Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians) (2011) (69)
- Programming of Adiposity in Offspring of Mothers With Type 1 Diabetes at Age 7 Years (2010) (69)
- Metabolic characterization of menopause: cross-sectional and longitudinal evidence (2017) (69)
- Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system (2014) (68)
- Cystatin C and Cardiovascular Disease (2016) (68)
- AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study (2011) (68)
- Associations of autozygosity with a broad range of human phenotypes (2019) (68)
- The effect of a programme to improve men’s sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial (2019) (68)
- Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes (2009) (67)
- High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. (2008) (67)
- The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. (2001) (66)
- Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study (2009) (66)
- Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction. (2012) (66)
- Genetic variation in the 15q25 nicotinic acetylcholine receptor gene cluster (CHRNA5–CHRNA3–CHRNB4) interacts with maternal self-reported smoking status during pregnancy to influence birth weight (2012) (66)
- Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. (1996) (66)
- Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. (2008) (66)
- The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes (2013) (66)
- A saturated map of common genetic variants associated with human height (2022) (65)
- Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort (2020) (65)
- Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study (2017) (65)
- Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Cardiometabolic Risk Factors in Adolescence: A Cross-Sectional Study of 1874 General Population Adolescents (2014) (65)
- Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men. (2003) (64)
- Range of Risk Factor Levels (2017) (64)
- Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. (2007) (63)
- Genetic Predictors of Fibrin D-Dimer Levels in Healthy Adults (2011) (63)
- Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis (2015) (63)
- Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis? (2011) (63)
- Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study. (2012) (62)
- Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. (1997) (62)
- The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better (2010) (62)
- Are there socioeconomic inequalities in cardiovascular risk factors in childhood, and are they mediated by adiposity? Findings from a prospective cohort study (2010) (62)
- Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program (2009) (62)
- Eplerenone and new‐onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS‐HF) (2012) (62)
- Influence of Adiposity on Insulin Resistance and Glycemia Markers Among U.K. Children of South Asian, Black African-Caribbean, and White European Origin (2013) (61)
- Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis (2022) (61)
- Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. (2007) (61)
- The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. (2011) (61)
- Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies (2017) (61)
- White Blood Cells and Blood Pressure A Mendelian Randomization Study (2020) (61)
- Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (2011) (60)
- Changes in micronutrient concentrations following anti-inflammatory treatment in patients with gastrointestinal cancer. (2000) (60)
- Red and processed meat consumption and breast cancer: UK Biobank cohort study and meta-analysis. (2018) (60)
- Effects of aldosterone receptor blockade in patients with mild–moderate heart failure taking a beta‐blocker (2007) (59)
- Reduced Glomerular Filtration Rate and Its Association with Clinical Outcome in Older Patients at Risk of Vascular Events: Secondary Analysis (2009) (59)
- Adipocytokines and risk of stroke in older people: a nested case-control study. (2009) (59)
- A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. (2011) (59)
- Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study (2021) (59)
- Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes? (2012) (59)
- Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial (2018) (59)
- Associations of discretionary screen time with mortality, cardiovascular disease and cancer are attenuated by strength, fitness and physical activity: findings from the UK Biobank study (2018) (59)
- Obesity and cancer (2006) (59)
- BMI and Mortality in UK Biobank: Revised Estimates Using Mendelian Randomization (2018) (59)
- ABC of obesity. Obesity and cancer. (2006) (59)
- Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People? (2008) (58)
- Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis (2016) (58)
- Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial. (2021) (58)
- Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study. (2009) (58)
- Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica (2016) (58)
- Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort (2013) (58)
- Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability (2020) (58)
- Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study (2013) (58)
- The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. (2002) (58)
- Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme (2018) (58)
- The incremental prognostic and clinical value of multiple novel biomarkers in heart failure (2016) (58)
- The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective (2014) (57)
- PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population[S] (2013) (57)
- Modifiable and non-modifiable risk factors for COVID-19: results from UK Biobank (2020) (57)
- Association between younger age when first overweight and increased risk for CKD. (2013) (56)
- A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis (2019) (56)
- Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes (2013) (56)
- A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis (2019) (56)
- Lipoprotein (a) levels in normal pregnancy and in pregnancy complicated with pre-eclampsia. (2000) (55)
- Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia in middle-aged South Asian compared with European men living in the UK (2013) (55)
- Tumour necrosis factor α blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study (2009) (55)
- Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. (2000) (55)
- Regular Breakfast Consumption and Type 2 Diabetes Risk Markers in 9- to 10-Year-Old Children in the Child Heart and Health Study in England (CHASE): A Cross-Sectional Analysis (2014) (55)
- Fine-mapping of an expanded set of type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps (2018) (55)
- Beating type 2 diabetes into remission (2017) (55)
- UK-born Pakistani-origin infants are relatively more adipose than white British infants: findings from 8704 mother-offspring pairs in the Born-in-Bradford prospective birth cohort (2013) (54)
- Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia (2017) (54)
- Associations of fat and carbohydrate intake with cardiovascular disease and mortality: prospective cohort study of UK Biobank participants (2020) (54)
- Early Antenatal Prediction of Gestational Diabetes in Obese Women: Development of Prediction Tools for Targeted Intervention (2016) (54)
- Dietary patterns in obese pregnant women; influence of a behavioral intervention of diet and physical activity in the UPBEAT randomized controlled trial (2016) (54)
- Sleep Duration and Risk of Type 2 Diabetes (2017) (54)
- Dose-response associations of cardiorespiratory fitness with all-cause mortality and incidence and mortality of cancer and cardiovascular and respiratory diseases: the UK Biobank cohort study (2019) (53)
- Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium (2015) (53)
- Association between grip strength and diabetes prevalence in black, South‐Asian, and white European ethnic groups: a cross‐sectional analysis of 418 656 participants in the UK Biobank study (2017) (53)
- Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2020) (53)
- Inflammation and Endothelial Activation Is Evident at Birth in Offspring of Mothers With Type 1 Diabetes (2007) (53)
- The co-ordinated cytokine/hormone response to acute injury incorporates leptin. (2000) (53)
- Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses (2011) (53)
- Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy (2018) (53)
- Assessing the Causal Role of Body Mass Index on Cardiovascular Health in Young Adults (2017) (53)
- Type 2 diabetes and risk of hospital admission or death for chronic liver diseases. (2016) (53)
- The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. (2011) (53)
- Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus. (2019) (53)
- Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: relevance of adiposity (2004) (52)
- N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS (2012) (52)
- Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies (2013) (52)
- Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. (2006) (52)
- Adiponectin and its association with bone mass accrual in childhood (2010) (52)
- Management: Part I—Behaviour change, diet, and activity (2006) (52)
- Human Placental Peroxisome Proliferator-Activated Receptor δ and γ Expression in Healthy Pregnancy and in Preeclampsia and Intrauterine Growth Restriction (2005) (52)
- Stratification by Smoking Status Reveals an Association of CHRNA5-A3-B4 Genotype with Body Mass Index in Never Smokers (2014) (52)
- &ggr;-Glutamyltransferase, Hepatic Enzymes, and Risk of Incident Heart Failure in Older Men (2012) (52)
- Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland (2012) (52)
- Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017 (2019) (52)
- Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: The ALSPAC study (2014) (51)
- Screen time is associated with adiposity and insulin resistance in children (2017) (51)
- Clinical management of type 2 diabetes in south Asia. (2018) (51)
- Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children. (2012) (51)
- Stress Hyperglycaemia in Hospitalised Patients and Their 3-Year Risk of Diabetes: A Scottish Retrospective Cohort Study (2014) (51)
- [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]. (2022) (50)
- The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP). (2020) (50)
- Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: heterogeneity of responses. (2007) (50)
- Ethnic Differences in Aortic Pulse Wave Velocity Occur in the Descending Aorta and May Be Related to Vitamin D (2011) (50)
- Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants (2016) (50)
- Effect of Socioeconomic Status on Mortality Among People With Type 2 Diabetes (2011) (50)
- Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction (2020) (50)
- Should Physical Activity Recommendations for South Asian Adults Be Ethnicity-Specific? Evidence from a Cross-Sectional Study of South Asian and White European Men and Women (2016) (50)
- N‐terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population‐based study (2014) (50)
- Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities (2012) (49)
- Insulin-sensitising agents in polycystic-ovary syndrome (1998) (49)
- Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease? (2004) (49)
- Physical Activity, Sedentary Behavior, and Inflammatory and Hemostatic Markers in Men (2017) (49)
- Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters (2007) (49)
- 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial. (2020) (49)
- Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes. (2018) (48)
- Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) (2013) (48)
- Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register (2018) (47)
- End-stage renal disease and survival in people with diabetes: a national database linkage study (2014) (47)
- Early-Life Overweight Trajectory and CKD in the 1946 British Birth Cohort Study (2013) (47)
- Essential fatty acids in relation to pregnancy complications and fetal development (1998) (47)
- Metabolic, inflammatory and haemostatic effects of a low‐dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? (2003) (47)
- Ethnic Differences in Glycaemic Control in People with Type 2 Diabetes Mellitus Living in Scotland (2013) (46)
- Adiponectin predicts insulin resistance but not endothelial function in young, healthy adolescents. (2005) (46)
- Persistent Iron Within the Infarct Core After ST-Segment Elevation Myocardial Infarction (2017) (46)
- Liver X receptor agonism promotes articular inflammation in murine collagen-induced arthritis. (2009) (46)
- Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? (2005) (46)
- Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity (2019) (46)
- "Anti-inflammatory" drugs and their effects on type 2 diabetes. (2006) (46)
- Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK Biobank (2018) (46)
- Ethnic Differences in Associations Between Fat Deposition and Incident Diabetes and Underlying Mechanisms: The SABRE Study (2015) (46)
- Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort (2017) (46)
- Lack of effect of TNFα blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies (2009) (46)
- PCSK 9 genetic variants and risk of type 2 diabetes : a mendelian randomisation study (2020) (45)
- Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease (2019) (45)
- Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence (2019) (45)
- Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use (2019) (45)
- In vivo multiplex molecular imaging of vascular inflammation using surface-enhanced Raman spectroscopy (2018) (45)
- Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation (2008) (45)
- Should Physical Activity Recommendations Be Ethnicity-Specific? Evidence from a Cross-Sectional Study of South Asian and European Men (2013) (45)
- Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants (2021) (45)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2019) (45)
- Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank (2019) (45)
- Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence. (2011) (44)
- White Blood Cells and Blood Pressure (2020) (44)
- Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial Infarction (2016) (44)
- Morning plasma cortisol as a cardiovascular risk factor: findings from prospective cohort and Mendelian randomization studies (2019) (44)
- Associations Between Dietary Fiber and Inflammation, Hepatic Function, and Risk of Type 2 Diabetes in Older Men: Potential Mechanisms for the Benefits of Fiber on Diabetes Risk (2010) (44)
- Leptin and Coronary Heart Disease Risk: Prospective Case Control Study of British Women (2007) (44)
- Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK Biobank participants (2016) (44)
- Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank (2020) (44)
- Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure. (2019) (44)
- Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence (2012) (43)
- EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome (2022) (43)
- Genome of the Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels (2015) (43)
- Socioeconomic Deprivation and Cortical Morphology: Psychological, Social, and Biological Determinants of Ill Health Study (2013) (43)
- ABC of obesity. Obesity and reproduction. (2006) (43)
- Activation of Hemostasis and Decline in Cognitive Function in Older People (2010) (43)
- Sitting Time and Waist Circumference Are Associated With Glycemia in U.K. South Asians (2011) (43)
- Renal function estimation and Cockcroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives (2016) (42)
- Nuclear magnetic resonance‐based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997 (2017) (42)
- Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction (2016) (42)
- Sustained influence of metformin therapy on circulating glucagon‐like peptide‐1 levels in individuals with and without type 2 diabetes (2017) (42)
- Consumption of dairy product and its association with total and cause specific mortality - A population-based cohort study and meta-analysis. (2019) (42)
- Time spent in sedentary posture is associated with waist circumference and cardiovascular risk (2017) (42)
- Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction (2019) (42)
- Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery. (2018) (42)
- Fruit juice: just another sugary drink? (2014) (42)
- Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. (2006) (42)
- The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome (2008) (42)
- Objectively Measured Physical Activity and Its Association With Adiponectin and Other Novel Metabolic Markers (2009) (41)
- Programming of Adiposity in Childhood and Adolescence: Associations With Birth Weight and Cord Blood Adipokines (2016) (41)
- Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction (2019) (41)
- Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNFα blockade: results from a prospective cohort study (2010) (41)
- Body Mass Index and Waist Circumference Cut-Points in Multi-Ethnic Populations from the UK and India: The ADDITION-Leicester, Jaipur Heart Watch and New Delhi Cross-Sectional Studies (2014) (41)
- Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality. (2019) (41)
- The potential for a two‐stage diabetes risk algorithm combining non‐laboratory‐based scores with subsequent routine non‐fasting blood tests: results from prospective studies in older men and women (2011) (41)
- Increasing physical activity in older adults using STARFISH, an interactive smartphone application (app); a pilot study (2017) (41)
- Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study (2017) (40)
- The association of grip strength with health outcomes does not differ if grip strength is used in absolute or relative terms: a prospective cohort study. (2019) (40)
- Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment (2018) (40)
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. (2021) (40)
- Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST) (2017) (40)
- Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer (2006) (40)
- High Blood Pressure and Its Association With Incident Diabetes Over 10 Years in the Korean Genome and Epidemiology Study (KoGES) (2015) (40)
- Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation. (2011) (40)
- Pregnancy glycaemia and cord-blood levels of insulin and leptin in Pakistani and white British mother–offspring pairs: findings from a prospective pregnancy cohort (2014) (40)
- Culturally adapting the prevention of diabetes and obesity in South Asians (PODOSA) trial. (2014) (40)
- Improving prevention strategies for cardiometabolic disease (2020) (39)
- Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project (2016) (39)
- Socio-Economic Position and Type 2 Diabetes Risk Factors: Patterns in UK Children of South Asian, Black African-Caribbean and White European Origin (2012) (39)
- IQ, Educational Attainment, Memory and Plasma Lipids: Associations with Apolipoprotein E Genotype in 5995 Children (2011) (39)
- The effects of tumor necrosis factor inhibitors on cardiovascular risk in rheumatoid arthritis. (2012) (39)
- Higher carotid‐radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes (2004) (39)
- Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2 (2014) (39)
- The association between insulin levels and cortical bone: Findings from a cross-sectional analysis of pQCT parameters in adolescents (2011) (38)
- The metabolic syndrome: should current criteria influence clinical practice? (2006) (38)
- The relationship of circulating insulin‐like growth factor 1, its binding protein‐3, prostate‐specific antigen and C‐reactive protein with disease stage in prostate cancer (2002) (38)
- Thrombosis Prophylaxis in Obstetrics and Gynaecology (1993) (38)
- Associations of maternal 25-hydroxyvitamin D in pregnancy with offspring cardiovascular risk factors in childhood and adolescence: findings from the Avon Longitudinal Study of Parents and Children (2013) (38)
- Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012–2014): a population-based observational study (2017) (38)
- Blood Biomarkers for the Diagnosis of Acute Cerebrovascular Diseases: A Prospective Cohort Study (2011) (38)
- Risk for Incident Heart Failure: A Subject‐Level Meta‐Analysis From the Heart “OMics” in AGEing (HOMAGE) Study (2017) (38)
- Do statins offer therapeutic potential in inflammatory arthritis? (2004) (38)
- Metabolic Effects of Breaking Prolonged Sitting With Standing or Light Walking in Older South Asians and White Europeans: A Randomized Acute Study (2018) (38)
- High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial☆ (2016) (38)
- The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes (2012) (38)
- Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016 (2019) (38)
- Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis (2018) (37)
- Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction. (2020) (37)
- Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study (2016) (37)
- Psychological, social and biological determinants of ill health (pSoBid): Study Protocol of a population-based study (2008) (37)
- Growth hormone replacement reduces C‐reactive protein and large‐artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency (2005) (37)
- The associations of sugar-sweetened, artificially sweetened and naturally sweet juices with all-cause mortality in 198,285 UK Biobank participants: a prospective cohort study (2020) (37)
- Impact of obesity on cardiovascular disease (2017) (37)
- Associations Between Prediabetes, by Three Different Diagnostic Criteria, and Incident CVD Differ in South Asians and Europeans (2015) (37)
- Prediction of gestational diabetes in obese pregnant women from the UK Pregnancies Better Eating and Activity (UPBEAT) pilot trial (2014) (37)
- Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction. (2020) (37)
- Ceramides: A new player in the inflammation–insulin resistance paradigm? (2009) (37)
- BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox (2019) (37)
- Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation (2020) (36)
- Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT) (2020) (36)
- Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study (2016) (36)
- The effect of graduated compression stockings on blood velocity in the deep venous system of the lower limb in the postnatal period (2007) (36)
- Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. (2010) (36)
- Diabetic cardiomyopathy (2018) (36)
- Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. (2005) (36)
- Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial (2017) (36)
- The association of fasting insulin, glucose, and lipids with bone mass in adolescents: findings from a cross-sectional study. (2012) (36)
- Overweight across the life course and adipokines, inflammatory and endothelial markers at age 60–64 years: evidence from the 1946 birth cohort (2015) (35)
- Circulating leptin concentrations and ovarian function in polycystic ovary syndrome. (2001) (35)
- Population-based secular trends in lower-extremity amputation for diabetes and peripheral artery disease (2019) (35)
- Ethnic Differences in Carotid Intima-Media Thickness Between UK Children of Black African-Caribbean and White European Origin (2012) (35)
- Edinburgh Research Explorer Effect of Socioeconomic Status on Mortality Among People With Type 2 Diabetes A study from the Scottish Diabetes Research Network Epidemiology Group (2011) (35)
- Achieved Levels of HbA1c and Likelihood of Hospital Admission in People With Type 1 Diabetes in the Scottish Population (2011) (35)
- N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR) (2013) (35)
- Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants. (2016) (35)
- Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP). (2021) (34)
- Study protocol of European Fans in Training (EuroFIT): a four-country randomised controlled trial of a lifestyle program for men delivered in elite football clubs (2016) (34)
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. (2016) (34)
- Personality, Socio-Economic Status and Inflammation: Cross-Sectional, Population-Based Study (2013) (34)
- The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease (2004) (34)
- Walking Pace Is Associated with Lower Risk of All-Cause and Cause-Specific Mortality (2019) (34)
- Lower concentrations of carotenoids in the critically ill patient are related to a systemic inflammatory response and increased lipid peroxidation. (2003) (34)
- Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register (2018) (34)
- Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies (2016) (34)
- Obesity—can we turn the tide? (2006) (34)
- Vegetarians, fish, poultry, and meat-eaters: who has higher risk of cardiovascular disease incidence and mortality? A prospective study from UK Biobank. (2020) (33)
- Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population. (2018) (33)
- Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin‐Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti‐PCSK9 Antibody in Statin‐Intolerant Subjects 3 (GAUSS‐3) Trial (2016) (33)
- Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus. (2017) (33)
- Association between fat mass through adolescence and arterial stiffness: a population-based study from The Avon Longitudinal Study of Parents and Children (2019) (33)
- Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm. (2013) (33)
- Unanswered questions over NHS health checks (2010) (33)
- Dietary lipids and vascular function: UK Food Standards Agency workshop report (2004) (33)
- Maternal Plasma DHA Levels Increase Prior to 29 Days Post-LH Surge in Women Undergoing Frozen Embryo Transfer: A Prospective, Observational Study of Human Pregnancy. (2016) (32)
- Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up (2014) (32)
- Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy (2012) (32)
- Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study (2016) (32)
- Why metabolic syndrome criteria have not made prime time: a view from the clinic (2008) (32)
- Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease (2016) (32)
- Adiposity, Adipokines, and Risk of Incident Stroke in Older Men (2013) (32)
- A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics. (2011) (32)
- Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials (2019) (32)
- Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group (2011) (32)
- Effects of low‐dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes (2007) (32)
- The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study (2019) (32)
- Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink. (2018) (32)
- Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis (TRACE RA): A multicenter, randomized, placebo controlled trial. (2019) (31)
- Distribution of adiponectin, leptin, and metabolic correlates of insulin resistance: a longitudinal study in British children; 1: Prepuberty (EarlyBird 15). (2008) (31)
- What Do Older People Do When Sitting and Why? Implications for Decreasing Sedentary Behavior (2018) (31)
- Maternal thyroid function and child educational attainment: prospective cohort study (2018) (31)
- Meta-analysis of genome-wide association studies of HDL cholesterol response to statins (2016) (31)
- Urinary proteomic biomarkers to predict cardiovascular events (2013) (31)
- Higher Body Mass Index in Adolescence Predicts Cardiomyopathy Risk in Midlife (2019) (31)
- Existing maternal obesity guidelines may increase inequalities between ethnic groups: a national epidemiological study of 502,474 births in England (2012) (30)
- Determinants of Intima-Media Thickness in the Young (2019) (30)
- Occupation and risk of COVID-19: prospective cohort study of 120,621 UK Biobank participants (2020) (30)
- Investigating the causal effect of smoking on hay fever and asthma: a Mendelian randomization meta-analysis in the CARTA consortium (2017) (30)
- Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial. (2021) (30)
- Selenium: An Acute-Phase Reactant? (1997) (30)
- Interaction of personality traits with social deprivation in determining mental wellbeing and health behaviours. (2012) (30)
- Effect of Evolocumab on Lipoprotein Particles. (2018) (30)
- The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: findings from the prospective British Women's Heart and Health Study. (2008) (30)
- Anti-Müllerian Hormone Is Not Associated with Cardiometabolic Risk Factors in Adolescent Females (2013) (30)
- SERRS immunoassay for quantitative human CRP analysis. (2008) (30)
- Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk (2014) (29)
- Association of N-Terminal Pro-Brain Natriuretic Peptide with Cognitive Function and Depression in Elderly People with Type 2 Diabetes (2012) (29)
- Epidemiology, risk factors, and opportunities for prevention of cardiovascular disease in individuals of South Asian ethnicity living in Europe. (2019) (29)
- Intergenerational change and familial aggregation of body mass index (2011) (29)
- Vascular function and cardiovascular risk factors in women with severe flushing (2011) (29)
- Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes (2020) (29)
- Discovery of novel heart rate-associated loci using the Exome Chip (2017) (29)
- Type 1 and Type 2 Diabetes and COVID-19 Related Mortality in England: A Cohort Study in People with Diabetes (2020) (29)
- Enhancement of endothelial function by pregnancy: inadequate response in women with type 1 diabetes. (2003) (29)
- Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels. (2004) (29)
- The effect of a lifestyle intervention in obese pregnant women on gestational metabolic profiles: findings from the UK Pregnancies Better Eating and Activity Trial (UPBEAT) randomised controlled trial (2019) (29)
- Diabetes drugs and stroke risk: Intensive versus conventional glucose‐lowering strategies, and implications of recent cardiovascular outcome trials (2020) (29)
- Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction. (2010) (29)
- Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial (2014) (29)
- Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective studies with 1,148,117 participants. (2020) (28)
- Vitamin D and chronic disease prevention (2014) (28)
- The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study (2020) (28)
- School dinners and markers of cardiovascular health and type 2 diabetes in 13-16 year olds: cross sectional study (2005) (28)
- Corrigendum to “Vitamin D concentrations and COVID-19 infection in UK Biobank” [Diabetes Metabol Syndr: Clin Res Rev 2020 14 (4) 561–5] (2020) (28)
- Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction. (2008) (28)
- IGF-1 and Leptin Associate With Fetal HDL Cholesterol at Birth (2007) (28)
- Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings (2020) (28)
- The Value of N-Terminal Pro–B-Type Natriuretic Peptide in Determining Antihypertensive Benefit: Observations From the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) (2014) (28)
- Leptin Levels and Depressive Symptoms in People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study (2012) (27)
- C-Reactive Protein and Genetic Variants and Cognitive Decline in Old Age: The PROSPER Study (2011) (27)
- Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study☆☆☆ (2013) (27)
- Effects of Acquired Obesity on Endothelial Function in Monozygotic Twins (2006) (27)
- Associations of childhood 25-hydroxyvitamin D2 and D3 and cardiovascular risk factors in adolescence: prospective findings from the Avon Longitudinal Study of Parents and Children (2014) (27)
- Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial (2017) (27)
- Analysis and modelling of cholesterol and high-density lipoprotein cholesterol changes across the range of C-reactive protein levels in clinical practice as an aid to better understanding of inflammation–lipid interactions (2013) (27)
- Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval (2013) (27)
- Adiposity among 132 479 UK Biobank participants; contribution of sugar intake vs other macronutrients. (2016) (27)
- Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial (2020) (27)
- Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis (2020) (27)
- Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial (2017) (27)
- Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. (2009) (27)
- Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. (2018) (27)
- Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease, and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking (2018) (27)
- Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits (2020) (26)
- Longitudinal Blood Pressure Control, Long-Term Mortality, and Predictive Utility of Serum Liver Enzymes and Bilirubin in Hypertensive Patients (2015) (26)
- Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes (2018) (26)
- The effect of increased ambulatory activity on markers of chronic low‐grade inflammation: evidence from the PREPARE programme randomized controlled trial (2010) (26)
- Associations of Gestational Weight Gain With Maternal Body Mass Index, Waist Circumference, and Blood Pressure Measured 16 Years After Pregnancy: The Avon Longitudinal Study of Parents and Children (2011) (26)
- Excess risk of hospitalisation for heart failure among people with type 2 diabetes (2018) (26)
- Markers of endothelial dysfunction and cerebral blood flow in older adults (2014) (26)
- Risk of metabolic and vascular disease in South Asians: potential mechanisms for increased insulin resistance (2008) (26)
- Stroke genetics informs drug discovery and risk prediction across ancestries (2022) (26)
- Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. (2022) (26)
- Association of Fitness and Grip Strength With Heart Failure: Findings From the UK Biobank Population-Based Study. (2019) (25)
- Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study (2016) (25)
- Serum leptin and cognitive function in people with Type 2 diabetes (2012) (25)
- Genetic determinants of metabolic syndrome components in the stroke-prone spontaneously hypertensive rat (2005) (25)
- Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial Infarction (2018) (25)
- Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9 (2018) (25)
- Cognitive and Kidney Function: Results from a British Birth Cohort Reaching Retirement Age (2014) (25)
- Total cerebral blood flow and mortality in old age (2013) (25)
- Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial (2021) (25)
- 25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. (2012) (25)
- Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies (2015) (25)
- Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes (2020) (25)
- Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care (2021) (25)
- Simultaneous activation of the liver X receptors (LXRα and LXRβ) drives murine collagen-induced arthritis disease pathology (2011) (25)
- Grip Strength and Walking Pace and Cardiovascular Disease Risk Prediction in 406,834 UK Biobank Participants. (2020) (25)
- High Innate Production Capacity of Proinflammatory Cytokines Increases Risk for Death from Cancer: Results of the PROSPER Study (2009) (24)
- The Upcoming Epidemic of Heart Failure in South Asia (2020) (24)
- Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland (2015) (24)
- Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure (2018) (24)
- Comparison of HapMap and 1000 Genomes Reference Panels in a Large-Scale Genome-Wide Association Study (2017) (24)
- Dietary fat and total energy intake modifies the association of genetic profile risk score on obesity: evidence from 48 170 UK Biobank participants (2017) (24)
- Novel coronary heart disease risk factors at 60–64 years and life course socioeconomic position: The 1946 British birth cohort (2015) (24)
- BMI and Mortality in Patients With New-Onset Type 2 Diabetes: A Comparison With Age- and Sex-Matched Control Subjects From the General Population (2018) (24)
- Circulating Concentrations of "Free" Leptin in Relation to Fat Mass and Appetite in Gastrointestinal Cancer Patients (2002) (24)
- Artificial intelligence framework for predictive cardiovascular and stroke risk assessment models: A narrative review of integrated approaches using carotid ultrasound (2020) (24)
- Do ethnic differences in cord blood leptin levels differ by birthweight category? Findings from the Born in Bradford cohort study (2013) (24)
- Review of economics studies (2011) (24)
- Socioeconomic Status and the Cerebellar Grey Matter Volume. Data from a Well-Characterised Population Sample (2013) (24)
- Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions. (2020) (24)
- HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards (2012) (24)
- Childhood Energy Intake Is Associated with Nonalcoholic Fatty Liver Disease in Adolescents123 (2015) (24)
- Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure. (2015) (24)
- Distinct Relationships of Intramuscular and Subcutaneous Fat With Cortical Bone: Findings From a Cross-Sectional Study of Young Adult Males and Females (2013) (23)
- Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies (2010) (23)
- Postnatal testing following gestational diabetes: time to replace the oral glucose tolerance test? (2015) (23)
- Impact of Selection Bias on Estimation of Subsequent Event Risk (2017) (23)
- Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme (2022) (23)
- Walking and inflammatory markers in individuals screened for type 2 diabetes. (2008) (23)
- "Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study. (2018) (23)
- Serum C-reactive protein and lipids in ultra-Marathon runners. (2004) (23)
- Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022) (23)
- Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans (2003) (22)
- Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers (2015) (22)
- Diagnosis of deep venous thrombosis in pregnancy: a new role for diagnostic ultrasound (1990) (22)
- Pharmacotherapy: Statins and new-onset diabetes—the important questions (2012) (22)
- Lipoprotein metabolism and vascular complications in pregnancy (2009) (22)
- Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial☆☆☆ (2018) (22)
- Diabetes, driving and fasting during Ramadan: the interplay between secular and religious law (2018) (22)
- Visceral adipose tissue activated macrophage content and inflammatory adipokine secretion is higher in pre-eclampsia than in healthy pregnancys (2017) (22)
- The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma. (2005) (22)
- Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? (2016) (22)
- Mechanisms of Sodium–Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics (2020) (22)
- Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles (2016) (22)
- Diabetes and cardiac disease in South Asians (2005) (21)
- White Matter Lesion Progression: Genome-Wide Search for Genetic Influences (2015) (21)
- Circulating IL-6 concentrations and associated anthropometric and metabolic parameters in South Asian men and women in comparison to European whites. (2013) (21)
- Summer–winter switching of the Ramadan fasts in people with diabetes living in temperate regions (2012) (21)
- Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial. (2019) (21)
- Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes. (2002) (21)
- Effect of Smoking on Blood Pressure and Resting Heart RateCLINICAL PERSPECTIVE (2015) (21)
- Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation? (2014) (21)
- Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis (2016) (21)
- High sensitivity C-reactive protein and cardiovascular disease: an association built on unstable foundations? (2006) (21)
- Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) (2011) (21)
- Hyperglycemia Has a Greater Impact on Left Ventricle Function in South Asians Than in Europeans (2014) (21)
- Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrations (2012) (21)
- Type 2 diabetes as an inflammatory disorder (2003) (21)
- Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial (2021) (21)
- Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events (2019) (21)
- Meal-induced inflammation: postprandial insights from the Personalised REsponses to DIetary Composition Trial (PREDICT) study in 1000 participants (2021) (21)
- Assessing for interaction between APOE ε4, sex, and lifestyle on cognitive abilities (2019) (20)
- Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients (2016) (20)
- Gestational diabetes modifies the association between PlGF in early pregnancy and preeclampsia in women with obesity (2018) (20)
- Determination of in vitro antidiabetic effects of Zingiber officinale Roscoe (2012) (20)
- Obesity and vascular disease (2006) (20)
- Impact of ethnicity on metabolic disturbance, vascular dysfunction and atherothrombotic cardiovascular disease (2005) (20)
- Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2017) (20)
- Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients (2021) (20)
- Fruit, vegetable and vitamin C intakes and plasma vitamin C: cross‐sectional associations with insulin resistance and glycaemia in 9–10 year‐old children (2015) (20)
- Metabolic Age Based on the BBMRI-NL 1H-NMR Metabolomics Repository as Biomarker of Age-related Disease (2020) (20)
- HELLP syndrome: mechanisms and management. (1999) (20)
- Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment (2018) (20)
- Non-Homologous End-Joining Pathway Associated with Occurrence of Myocardial Infarction: Gene Set Analysis of Genome-Wide Association Study Data (2013) (20)
- Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) (2022) (20)
- A dysglycaemic effect of statins in diabetes: relevance to clinical practice? (2014) (20)
- Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study (2021) (20)
- Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015 (2019) (20)
- Child maltreatment and cardiovascular disease: quantifying mediation pathways using UK Biobank (2020) (19)
- Thromboembolic Risk in Hospitalised and Non-hospitalised Covid-19 Patients: A Self-controlled Case Series Analysis of a Nation-wide Cohort (2021) (19)
- High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk (2016) (19)
- Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies (2018) (19)
- Triglycerides and coronary heart disease: have recent insights yielded conclusive answers? (2009) (19)
- Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium (2015) (19)
- Artificial reproductive technology and the risk of venous thromboembolic disease (2006) (19)
- Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future (2016) (19)
- Ethnic and socioeconomic differences in SARS-CoV2 infection in the UK Biobank cohort study (2020) (19)
- Reproducibility and Repeatability of Peripheral Microvascular Assessment Using Iontophoresis in Conjunction With Laser Doppler Imaging (2007) (19)
- A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time (2020) (19)
- In fl uence of Adiposity on Insulin Resistance and GlycemiaMarkers Among United Kingdom Children of South Asian , Black African-Caribbean , andWhite European Origin Child Heart and Health Study in England (2013) (19)
- Birthweight and risk markers for type 2 diabetes and cardiovascular disease in childhood: the Child Heart and Health Study in England (CHASE) (2014) (18)
- Childhood Obesity: A Ticking Time Bomb for Cardiovascular Disease? (2011) (18)
- Metabolomic profiles predict individual multidisease outcomes (2022) (18)
- Adiposity and cardiovascular outcomes in three‐year‐old children of participants in UPBEAT, an RCT of a complex intervention in pregnant women with obesity (2020) (18)
- Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. (2001) (18)
- Ramadan fasting: recommendations for patients with cardiovascular disease (2021) (18)
- Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial. (2022) (18)
- Associations of Dietary Protein Intake With Fat-Free Mass and Grip Strength: A Cross-Sectional Study in 146,816 UK Biobank Participants (2018) (18)
- The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome. (2007) (18)
- The effects of remote ischaemic preconditioning on coronary artery function in patients with stable coronary artery disease (2018) (18)
- Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis. (2009) (18)
- Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements? (2004) (18)
- N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study (2014) (17)
- Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar (2008) (17)
- Changes in six domains of cognitive function with reproductive and chronological ageing and sex hormones: a longitudinal study in 2411 UK mid-life women (2020) (17)
- Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? (2004) (17)
- Infant Body Composition and Adipokine Concentrations in Relation to Maternal Gestational Weight Gain (2014) (17)
- Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF (2022) (17)
- COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records (2022) (17)
- Changes in marital quality over 6 years and its association with cardiovascular disease risk factors in men: findings from the ALSPAC prospective cohort study (2017) (17)
- Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents (2014) (17)
- Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted? (2013) (17)
- Meta-analyses of Results From Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes (2021) (17)
- Abstract 17070: Efficacy and Safety of Alirocumab: Pooled Analyses of 1048 Individuals With Diabetes Mellitus From Five Placebo-controlled Phase 3 Studies of at Least 52 Weeks Duration (2015) (17)
- Fatty acid status of women of reproductive age (2001) (17)
- Yoga and Cardiovascular Health Trial (YACHT): a UK-based randomised mechanistic study of a yoga intervention plus usual care versus usual care alone following an acute coronary event (2019) (17)
- Prenatal Exposures and Anti-Müllerian Hormone in Female Adolescents (2013) (17)
- Association of Circulating Metabolites in Plasma or Serum and Risk of Stroke (2020) (17)
- Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP 5 and STX 2 (2014) (17)
- How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes? (2020) (17)
- Relationship between outdoor temperature and cardiovascular disease risk factors in older people (2016) (17)
- Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes (2017) (17)
- Combined cardiovascular and diabetes risk assessment in primary care (2011) (16)
- Cardiovascular and Mortality Risks in Migrant South Asians with Type 2 Diabetes: Are We Winning the Battle? (2017) (16)
- Association of maternal exposures with adiposity at age 4/5 years in white British and Pakistani children: findings from the Born in Bradford study (2017) (16)
- Secretory Phospholipase A2-IIA and Cardiovascular Disease A Mendelian Randomization Study (2017) (16)
- A multisystem, cardio-renal investigation of post-COVID-19 illness (2022) (16)
- Do nuclear magnetic resonance (NMR)-based metabolomics improve the prediction of pregnancy-related disorders? Findings from a UK birth cohort with independent validation (2020) (16)
- A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium (2016) (16)
- Genetic analysis of over half a million people characterises C-reactive protein loci (2022) (16)
- Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study (2020) (16)
- Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis. (2010) (16)
- Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes (2004) (16)
- Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes (2013) (16)
- Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. (2015) (16)
- Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF (2022) (16)
- Incident ischaemic stroke and Type 2 diabetes: trends in incidence and case fatality in Scotland 2004–2013 (2018) (16)
- Heart Failure Epidemiology in Patients With Diabetes Mellitus Without Coronary Heart Disease. (2019) (16)
- Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study (2022) (16)
- Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study (2018) (16)
- C-reactive protein is an independent predictor of risk for the development of diabetes mellitus in the West of Scotland Coronary Prevention Study (2002) (16)
- Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study (2021) (16)
- Advances in the clinical management of type 2 diabetes: a brief history of the past 15 years and challenges for the future (2019) (16)
- Genome-wide association study of circulating interleukin 6 levels identifies novel loci (2021) (16)
- Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease? (2012) (16)
- Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis (2021) (16)
- BMI and mortality among adults with incident type 2 diabetes. (2014) (15)
- Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized placebo-controlled trial. (2016) (15)
- Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease (2018) (15)
- Left Ventricular Hypertrophy and Cognitive Decline in Old Age. (2017) (15)
- Lower thresholds for diagnosis and management of obesity in British South Asians (2011) (15)
- Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC) (2017) (15)
- In Preeclampsia, Maternal Third Trimester Subcutaneous Adipocyte Lipolysis Is More Resistant to Suppression by Insulin Than in Healthy Pregnancy (2014) (15)
- Physical capability markers used to define sarcopenia and their association with cardiovascular and respiratory outcomes and all-cause mortality: A prospective study from UK Biobank. (2020) (15)
- Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly (2009) (15)
- Prediction of uncomplicated pregnancies in obese women: a prospective multicentre study (2017) (15)
- Excess Cardiovascular Risk in Type 1 Diabetes Mellitus: Role for a Dysfunctional Immune Response? (2019) (15)
- Prediction of uncomplicated pregnancies in obese women: a prospective multicentre study (2017) (15)
- The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT): Testing C-Reactive Protein at Baseline and on-Treatment as an Independent Predictor of Cardiovascular Outcomes (2010) (15)
- Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank (2019) (15)
- Does the LDL receptor play a role in the risk of developing type 2 diabetes? (2015) (15)
- Hormone Replacement Therapy and Cardiovascular Risk in Post‐menopausal Women with NIDDM (1996) (15)
- Variation in the SLC23A1 gene does not influence cardiometabolic outcomes to the extent expected given its association with l-ascorbic acid1234 (2014) (15)
- Does rimonabant pull its weight for type 2 diabetes? (2006) (15)
- Low molecular weight heparin for pregnancy complications? (2009) (15)
- Sex differences in the association of risk factors for heart failure incidence and mortality (2019) (15)
- The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study. (2020) (15)
- Dietary and physical activity recommendations to prevent type 2 diabetes in South Asian adults: A systematic review (2018) (14)
- Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants (2021) (14)
- Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study (2017) (14)
- Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing. (2016) (14)
- Body Mass Index in Young Women and Risk of Cardiomyopathy (2020) (14)
- SAT0105 Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Rheumatoid Arthritis (TRACE RA) (2015) (14)
- Foot Ulcer and Risk of Lower Limb Amputation or Death in People With Diabetes: A National Population-Based Retrospective Cohort Study. (2021) (14)
- Relationship between myometrial resistance artery behavior and circulating lipid composition. (1999) (14)
- Estimating the Effect of Liver and Pancreas Volume and Fat Content on Risk of Diabetes: A Mendelian Randomization Study. (2021) (14)
- Potential sensing of toxic chemical warfare agents (CWAs) by twisted nanographenes: A first principle approach. (2022) (14)
- Association of injury related hospital admissions with commuting by bicycle in the UK: prospective population based study (2020) (14)
- Subsequent Event Risk in Individuals With Established Coronary Heart Disease (2019) (14)
- Lessons from SAVOR and EXAMINE: some important answers, but many open questions. (2014) (14)
- Hot flushes, vascular reactivity and the role of the α-adrenergic system (2012) (14)
- Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (2021) (14)
- Association of SBP and BMI with cognitive and structural brain phenotypes in UK Biobank. (2020) (14)
- Systemic Inflammation and Cardio-Renal Organ Damage Biomarkers in Middle Age Are Associated With Physical Capability Up to 9 Years Later (2019) (14)
- Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add‐on to metformin in patients with type 2 diabetes (2020) (14)
- NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study. (2010) (14)
- ABC of obesity: obesity and vascular disease. (2006) (14)
- Potential Benefits and Harms of Gastric Bypass Surgery in Obese Individuals With Type 1 Diabetes: A Nationwide, Matched, Observational Cohort Study (2020) (14)
- The Relation of Rapid Changes in Obesity Measures to Lipid Profile - Insights from a Nationwide Metabolic Health Survey in 444 Polish Cities (2014) (14)
- N‐terminal pro–brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk (2014) (14)
- Cardiorenal risk reduction guidance in diabetes: can we reach consensus? (2020) (14)
- The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: findings from a cross-sectional study (2015) (13)
- Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time (2020) (13)
- Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001–2007 (2013) (13)
- A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk (2022) (13)
- Hepatic VLDL overproduction: is hyperinsulinemia or insulin resistance the culprit? (2011) (13)
- Associations of muscle mass and grip strength with severe NAFLD: a prospective study of 333,295 UK Biobank participants. (2022) (13)
- Review: Diabetes and cardiac disease in South Asians: (2005) (13)
- Large-scale pharmacogenomic study of sulfonylureas and the QT, JT, and QRS intervals: CHARGE Pharmacogenomics Working Group (2016) (13)
- Randomised controlled trial to assess the impact of a lifestyle intervention (ActWELL) in women invited to NHS breast screening (2018) (13)
- Which Circulating Antioxidant Vitamins Are Confounded by Socioeconomic Deprivation? The MIDSPAN Family Study (2010) (13)
- Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial. (2021) (13)
- Improving pregnancy outcome in obese women: the UK Pregnancies Better Eating and Activity randomised controlled Trial (2017) (13)
- Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population (2021) (13)
- C-Reactive Protein and Prognosis in Diabetes: Getting to the Heart of the Matter (2009) (12)
- Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study (2019) (12)
- Correction: The effect of a programme to improve men's sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial (2019) (12)
- Development and validation of a cardiovascular risk prediction model in type 1 diabetes (2021) (12)
- The association between a lifestyle score, socioeconomic status, and COVID-19 outcomes within the UK Biobank cohort (2022) (12)
- Relationship Between Blood Pressure Values, Depressive Symptoms, and Cardiovascular Outcomes in Patients With Cardiometabolic Disease (2016) (12)
- The British Women’s Heart and Health Study and meta-analysis (2018) (12)
- Rheumatoid arthritis: Debunking the obesity–mortality paradox in RA (2015) (12)
- Erythrocytosis in offspring of mothers with Type 1 diabetes—are factors other than insulin critical determinants? (2009) (12)
- Behavior of Insulin Resistance and Its Metabolic Correlates in Prepubertal Children (2007) (12)
- Associations between grip strength and incident type 2 diabetes: findings from the UK Biobank prospective cohort study (2021) (12)
- Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles. (2002) (12)
- Associations of Pregnancy Complications with Calculated CVD Risk and Cardiovascular Risk Factors in Middle Age: The Avon Longitudinal Study of Parents and Children (2012) (12)
- University of Dundee Stratification by Smoking Status Reveals an Association of CHRNA 5-A 3-B 4 Genotype with Body Mass Index in Never Smokers (2014) (12)
- Review: Adipose tissue: passive sump or active pump? (2001) (12)
- Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function (2022) (12)
- Metabolic biomarkers for peripheral artery disease compared with coronary artery disease: Lipoprotein and metabolite profiling of 31,657 individuals from five prospective cohorts (2020) (12)
- Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin. (2022) (11)
- Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: Findings from a large cross-sectional study (2014) (11)
- Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 Individuals Across 13 Cohorts (2022) (11)
- Advances in managing type 2 diabetes: challenging old paradigms and developing new ones (2014) (11)
- Investigating Endothelial Activation and Oxidative Stress in relation to Glycaemic Control in a Multiethnic Population (2012) (11)
- Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales (2021) (11)
- Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT) (2021) (11)
- Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies (2021) (11)
- Prospective Study and Systematic Review (2009) (11)
- Review: PCOS, insulin resistance and long-term risks for diabetes and vascular disease (2009) (11)
- Superficial Vein Thrombosis (2013) (11)
- Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes (2017) (11)
- Men across a range of ethnicities have a higher prevalence of diabetes: findings from a cross‐sectional study of 500 000 UK Biobank participants (2018) (11)
- Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin. (2022) (11)
- Physical Activity Is Prospectively Associated With Adolescent Nonalcoholic Fatty Liver Disease (2015) (11)
- Smoking and diabetes risk: building a causal case with clinical implications. (2015) (11)
- Association between plasma plasminogen activator inhibitor-1 and survival in colorectal cancer (1998) (11)
- High-Sensitivity Troponin T and Incident Heart Failure in Older Men: British Regional Heart Study (2019) (11)
- Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland (2021) (11)
- Metabolic syndrome criteria: ready for clinical prime time or work in progress? (2005) (11)
- A COMPREHENSIVE SAFETY ANALYSIS OF 6026 PATIENTS FROM PHASE 2 AND 3 SHORT AND LONG TERM CLINICAL TRIALS WITH EVOLOCUMAB (AMG 145) (2015) (10)
- Associations of moderate-to-vigorous-intensity physical activity and body mass index with glycated haemoglobin within the general population: a cross-sectional analysis of the 2008 Health Survey for England (2017) (10)
- Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities (2019) (10)
- Persistence of infarct zone T2 hyperintensity at 6 months after acute ST-elevation myocardial infarction: incidence, pathophysiology and prognostic implications (2017) (10)
- Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers (2020) (10)
- Do physical activity, commuting mode, cardiorespiratory fitness and sedentary behaviours modify the genetic predisposition to higher BMI? Findings from a UK Biobank study (2019) (10)
- Prenatal exposures and anti-Mllerian hormone in female adolescents: the Avon longitudinal study of parents and children (2013) (10)
- How low to aim in rheumatoid arthritis? Learning from other disciplines (2013) (10)
- Why should we consider a life course approach to women's health care. (2011) (10)
- Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study (2019) (10)
- Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease. (2018) (10)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (10)
- Metabolic syndrome and diabetes mellitus. (2004) (10)
- An Investigation of Two-Dimensional Ultrasound Carotid Plaque Presence and Intima Media Thickness in Middle-Aged South Asian and European Men Living in the United Kingdom (2015) (10)
- Insights from apoB: from better diagnosis & therapy to the Medusa Hypothesis. (2004) (10)
- Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young (2022) (10)
- Lipids and the pathogenesis of pre-eclampsia (1999) (10)
- Is the adiposity‐associated FTO gene variant related to all‐cause mortality independent of adiposity? Meta‐analysis of data from 169,551 Caucasian adults (2015) (9)
- Life Course Socioeconomic Position: Associations with Cardiac Structure and Function at Age 60-64 Years in the 1946 British Birth Cohort (2016) (9)
- PCSK9 inhibitors and diabetes risk: a question worth asking? (2016) (9)
- Cohort profile: National Diabetes Audit for England and Wales (2021) (9)
- Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses (2020) (9)
- Knowledge and Beliefs Regarding Thalassemia in an Urban Population (2019) (9)
- Impact of Kidney Function on Cardiovascular Risk and Mortality: A Comparison of South Asian and European Cohorts (2019) (9)
- Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation (2022) (9)
- No Evidence for Genome-Wide Interactions on Plasma Fibrinogen by Smoking, Alcohol Consumption and Body Mass Index: Results from Meta-Analyses of 80,607 Subjects (2014) (9)
- Effects of Intracoronary Alteplase on Microvascular Function in Acute Myocardial Infarction (2020) (9)
- Research digest (2010) (9)
- Induction of labour: new horizons. (1998) (9)
- Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial (2021) (9)
- Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease (2020) (9)
- Pre-eclampsia associated with Helicobacter pylori seropositivity. (2006) (9)
- Association of Cardiometabolic Multimorbidity With Mortality The Emerging Risk Factors Collaboration (2015) (9)
- The obesity paradox in secondary prevention: a weighty intervention or a wait for more evidence? (2020) (9)
- Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled Trials (2021) (9)
- Metabolic syndrome: collapsing under its own weight? (2009) (9)
- Vitamin D insufficiency. (2011) (9)
- Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes (2022) (9)
- Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence (2006) (9)
- In fl uence of Adiposity on Insulin Resistance and Glycemia Markers Among U.K. Children of South Asian, Black African-Caribbean, and White European Origin Child Heart and Health Study in England (2013) (9)
- Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies (2020) (9)
- PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study (2020) (9)
- Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes. (2018) (8)
- Contrasting Associations of Body Mass Index and Hemoglobin A1c on the Excess Risk of Acute Myocardial Infarction and Heart Failure in Type 2 Diabetes Mellitus (2019) (8)
- Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study (2021) (8)
- Effect of non‐surgical weight management on weight and glycaemic control in people with type 2 diabetes: A comparison of interventional and non‐interventional outcomes at 3 years (2018) (8)
- The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis. (2005) (8)
- Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. (2022) (8)
- Potential Effects of Bariatric Surgery on the Incidence of Heart Failure and Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus and Obesity and on Mortality in Patients With Preexisting Heart Failure: A Nationwide, Matched, Observational Cohort Study (2021) (8)
- Statin treatment of rheumatoid arthritis: comment on the editorial by Ridker and Solomon. (2010) (8)
- Epidemiology of type 2 diabetes remission in Scotland in 2019: A cross-sectional population-based study (2021) (8)
- The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale descriptive analysis of trends in medication data (2022) (8)
- Patient stratification for determining optimal second and third line therapy for type 2 diabetes: the TriMaster study (2022) (8)
- Prevention of CV outcomes in antihyperglycaemic drug-naïve patients with type 2 diabetes with, or at elevated risk of, ASCVD: to start or not to start with metformin. (2020) (8)
- Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss (2021) (8)
- The antiinflammatory effects of statins. (2001) (8)
- Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study (2020) (8)
- Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction (2017) (8)
- In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. (2014) (8)
- The Association of Rate of Weight Gain During Early Adulthood With the Prevalence of Subclinical Coronary Artery Disease in Recently Diagnosed Type 2 Diabetes: The MAXWEL-CAD Study (2014) (8)
- Type 2 diabetes , chronic liver disease and hepatocellular cancer : a national retrospective cohort study using linked routine data (2016) (8)
- Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006–2019: A cohort study (2021) (8)
- Type 2 diabetes-related sex differences in cardiovascular risk: reasons, ramifications, and clinical realities. (2019) (8)
- Understanding How Much TV is Too Much: A Nonlinear Analysis of the Association Between Television Viewing Time and Adverse Health Outcomes. (2020) (8)
- Association of Factor V Leiden With Subsequent Atherothrombotic Events (2020) (8)
- A novel approach to increasing community capacity for weight management a volunteer-delivered programme (ActWELL) initiated within breast screening clinics: a randomised controlled trial (2021) (8)
- Antioxidant activities of Z. officinale Roscoe and A. allughas Roscoe (Zingiberaceae) Rhizomes (2013) (8)
- Handgrip strength and all‐cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study (2022) (8)
- Blood Lipids and Type 2 Diabetes Risk: Can Genetics Help Untangle the Web? (2015) (8)
- Hormone replacement therapy in Type 2 diabetes mellitus: a cardiovascular perspective (1998) (8)
- Associations between weight change and biomarkers of cardiometabolic risk in South Asians: secondary analyses of the PODOSA Trial (2016) (8)
- HOT FLUSHES , VASCULAR REACTIVITY AND THE ROLE OF THE ALPHA-ADRENERGIC SYSTEM (2012) (8)
- Associations of dietary protein intake with bone mineral density: An observational study in 70,215 UK Biobank participants. (2019) (8)
- POS11 Blood markers and poor outcome after acute cerebrovascular disease: a prospective cohort study (2010) (8)
- Socio‐economic status and mortality in people with type 1 diabetes in Scotland 2006–2015: a retrospective cohort study (2020) (8)
- Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study. (2020) (7)
- Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA‐REG OUTCOME trial (2021) (7)
- TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol (2020) (7)
- Research: Treatment Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006–2008 (2014) (7)
- Objectively measured physical activity and cardiac biomarkers: A cross sectional population based study in older men (2018) (7)
- Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
- Design and baseline characteristics of the AMPLITUDE‐O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist (2020) (7)
- Management of Lipid Abnormalities in Patients with Diabetes (2019) (7)
- Longitudinal changes in reproductive hormones through the menopause transition in the Avon Longitudinal Study of Parents and Children (ALSPAC) (2020) (7)
- Potential relevance of changes in haematocrit to changes in lipid parameters with empagliflozin in patients with type 2 diabetes (2016) (7)
- Edinburgh Research Explorer Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008 (2014) (7)
- Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach. (2009) (7)
- Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study (2022) (7)
- A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High‐Sensitivity Cardiac Troponin‐I in Subjects With Stable Cardiovascular Disease (2018) (7)
- Predicting biological age based on the BBMRI-NL 1H-NMR metabolomics repository (2019) (7)
- Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity (2017) (7)
- Weight loss‐induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT) (2020) (7)
- Adiponectin and raised mortality in type 1 diabetes: any credible explanatory mechanisms? * (2011) (7)
- Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease—results of the Immune Metabolic Associations in Psoriatic Arthritis study (2021) (7)
- Cross-sectional associations between personality traits and device-based measures of step count and sedentary behaviour in older age: the Lothian Birth Cohort 1936 (2019) (7)
- Ethnic differences in cardiovascular risk: examining differential exposure and susceptibility to risk factors (2022) (7)
- Alzheimer’s disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769) (2020) (7)
- Nonexercise Equations to Estimate Fitness in White European and South Asian Men. (2016) (7)
- Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort study (2021) (7)
- Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis (2021) (7)
- Natural and synthetic LPS and lipid a analogs or partial structures that antagonize or induce tolerance to LPS. (1998) (7)
- Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo (2003) (7)
- Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study. (2020) (7)
- Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. (2022) (6)
- Brief formula low-energy-diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT). (2021) (6)
- Response by Sattar et al to Letters Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks". (2019) (6)
- Risk of mortality among inpatients with COVID‐19 and type 2 diabetes: National data from Kuwait (2021) (6)
- Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease (2016) (6)
- Epidemiological evidence against a role for C-reactive protein causing leptin resistance. (2012) (6)
- Diverging trends for onset of acute myocardial infarction, heart failure, stroke and mortality in young males: role of changes in obesity and fitness (2021) (6)
- Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling (2021) (6)
- The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis (2020) (6)
- PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS) (2020) (6)
- Understanding COVID-19 trajectories from a nationwide linked electronic health record cohort of 56 million people: phenotypes, severity, waves & vaccination (2021) (6)
- Genome-wide association study of cardiac troponin I in the general population (2021) (6)
- EMPAGLIFLOZIN IS ASSOCIATED WITH A LOWER RISK OF POST-ACUTE HEART FAILURE RE-HOSPITALIZATION AND MORTALITY: INSIGHTS FROM THE EMPA-REG OUTCOME TRIAL (2019) (6)
- A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids (2021) (6)
- Incidence and Characteristics of Remission of Type 2 Diabetes in England: A Cohort Study Using the National Diabetes Audit. (2022) (6)
- Evidence of a common causal relationship between body mass index and inflammatory skin disease: a Mendelian Randomization study (2018) (6)
- Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. (2008) (6)
- A relationship between myometrial resistance artery behaviour and circulating lipid composition (1998) (6)
- Physical activity and lipidomics in a population at high risk of type 2 diabetes mellitus (2020) (6)
- Vitamin D genes and mortality (2014) (6)
- Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset (2021) (6)
- Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction (2019) (6)
- Osteoporosis and Its Association With Cardiovascular Disease, Respiratory Disease, and Cancer: Findings From the UK Biobank Prospective Cohort Study. (2022) (6)
- Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials. (2019) (6)
- Prognostic Implications of N-terminal Pro-B Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved. (2022) (6)
- Efficacy and Safety of the PCSK9 Inhibitor Evolocumab (AMG 145) in Patients with Type 2 Diabetes (2015) (6)
- Evaluation of the one-year efficacy, safety and glycaemic effects of evolocumab (AMG 145) in 4,802 subjects with, at high risk for, or at low risk for, diabetes mellitus (2015) (6)
- Research digest: vitamin D supplementation. (2019) (6)
- C-reactive protein and hormone replacement therapy. (2000) (5)
- Glycaemic Effects of Non-statin Lipid-Lowering Therapies (2016) (5)
- The G-to-T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia (2003) (5)
- Classification of reported statin intolerance. (2015) (5)
- IL-33 reduces the development of atherosclerosis (2012) (5)
- Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end‐stage renal disease (2020) (5)
- TRIAL OF ATORVASTATIN FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH RA (TRACE RA): A RANDOMIZED TRIAL IN 2986 RA PATIENTS (2015) (5)
- Metabolic phenotyping by treatment modality in obese women with gestational diabetes suggests diverse pathophysiology: An exploratory study (2020) (5)
- Pre-conception maternal erythrocyte saturated to unsaturated fatty acid ratio predicts pregnancy after natural cycle frozen embryo transfer (2018) (5)
- Genome-wide association study provides new insights into the genetic architecture and pathogenesis of heart failure (2019) (5)
- Polycystic ovarian syndrome: vascular and metabolic issues (2006) (5)
- Low vitamin D levels are related to left ventricular concentric remodelling in men of different ethnic groups with varying cardiovascular risk. (2012) (5)
- PCSK9 genetic variants, life-long lowering of LDL-cholesterol and cognition: a large-scale Mendelian randomization study (2018) (5)
- Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017 (2020) (5)
- Estimated Life-Years Gained Free of New or Recurrent Major Cardiovascular Events With the Addition of Semaglutide to Standard of Care in People With Type 2 Diabetes and High Cardiovascular Risk. (2022) (5)
- Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. (2003) (5)
- The Behaviour of Insulin Resistance and its Metabolic Correlates in Pre-pubertal Children: a Longitudinal Study (EarlyBird 32) (2007) (5)
- Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica (2022) (5)
- Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease (2022) (5)
- Edinburgh Research Explorer The Relationship Between Metabolic Risk Factors and Incident Cardiovascular Disease in Europeans, South Asians, and African Caribbeans SABRE (Southall and Brent Revisited)-A Prospective Population-Based Study (2018) (5)
- Bedside detection of awareness in the vegetative state (2012) (5)
- Obesity in Children and Future Cardiometabolic Risk (2010) (5)
- Managing Cardiovascular Risk in Patients with Rheumatic Disease. (2021) (5)
- Social Media and BBC Arabic: A case study of ‘Nuqtat Hewar’ (2012) (5)
- Two-year results of the randomised Diabetes Remission Clinical Trial (DiRECT) (2019) (5)
- Skeletal Muscle and Metabolic Health: How Do We Increase Muscle Mass and Function in People with Type 2 Diabetes? (2020) (5)
- The impact of the COVID-19 pandemic on cardiovascular disease prevention and management (2023) (5)
- Insulin resistance is a risk factor for diabetes but not cardiovascular disease in the elderly: results from long-term follow-up of the Prospective Study of Pravastatin in the Elderly at Risk trial (2014) (5)
- Congenital anomalies of kidney and urinary tract (2013) (5)
- Endothelial Function in Patients with Proteinuric Primary Glomerulonephritis (2008) (5)
- Predictors of the Acute Postprandial Response to Breaking Up Prolonged Sitting. (2019) (5)
- Body mass index and mortality in UK Biobank: revised estimates using Mendelian randomization (2018) (5)
- Comparing the interobserver reproducibility of different regions of interest on multi-parametric renal magnetic resonance imaging in healthy volunteers, patients with heart failure and renal transplant recipients (2019) (5)
- Research digest: SGLT2 inhibition in kidney and liver disease. (2019) (5)
- Association of High-Density Lipoprotein Cholesterol With Cognitive Function: Findings From the PROspective Study of Pravastatin in the Elderly at Risk (2020) (5)
- Is it Safe for Patients With COVID-19 to Fast in Ramadan? (2020) (5)
- Lipid-Modifying Therapies and Risk of Pancreatitis (2012) (5)
- Associations of social and economic and pregnancy exposures with blood pressure in UK White British and Pakistani children age 4/5 (2018) (5)
- Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295–303 (2015) (5)
- A complex intervention to improve outcome in obese pregnancies; the upbeat study (2011) (4)
- Body weight and mortality in type 2 diabetes: weighing up the evidence. (2013) (4)
- Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial (2021) (4)
- VLCD for weight loss and remission of type 2 diabetes? – Authors' reply (2018) (4)
- Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769). (2020) (4)
- Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity – a cross-sectional study (2020) (4)
- The metabolic syndrome: setting the scene. The cons (2007) (4)
- Shorter sleep: a new potential target to address cardiovascular and metabolic risk? (2019) (4)
- Macronutrients and cardiovascular risk in a global context. (2017) (4)
- Eff ect of a behavioural intervention in obese pregnant women ( the UPBEAT study ) : a multicentre , randomised controlled trial (2015) (4)
- Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical data (2021) (4)
- Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptide (2016) (4)
- SurgiCal Obesity Treatment Study (SCOTS): protocol for a national prospective cohort study of patients undergoing bariatric surgery in Scotland (2015) (4)
- Comparison of mortality in people with type 1 and type 2 diabetes by age of diagnosis: an incident population-based study in England and Wales. (2021) (4)
- Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts (2021) (4)
- Epidemiology and Prevention Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age (2012) (4)
- Estimating the causal effect of BMI on mortality risk in people with heart disease, diabetes and cancer using Mendelian randomization. (2021) (4)
- Metformin: framed again? (2009) (4)
- Metformin and carotid intima‐media thickness in never‐smokers with type 1 diabetes: The REMOVAL trial (2020) (4)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (4)
- Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort (2021) (4)
- Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data (2022) (4)
- Network Meta‐Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid‐Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low‐Density Lipoprotein Cholesterol (2022) (4)
- Association analysis of vitamin D receptor gene polymorphisms in North England population with Type 2 diabetes mellitus (2021) (4)
- Body-mass index and cardiometabolic disease: a Mendelian randomisation study of UK Biobank participants (2016) (4)
- Implications of the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines and potential value of the coronary artery calcium score among South Asians in the US: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study. (2021) (4)
- 103 Routine assessment of iron status in all patients with heart failure may identify those at risk of developing anaemia (2007) (4)
- Research digest: the risks of type 2 diabetes at a young age. (2017) (4)
- Remote history of VTE is associated with severe COVID‐19 in middle and older age: UK Biobank cohort study (2021) (4)
- Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD) (2020) (4)
- Complications of Diabetes: An Insight into Genetic Polymorphism and Role of Insulin. (2018) (4)
- Statins as novel therapies for osteoporosis? (2002) (4)
- Postprandial Vascular Dysfunction Is Associated With Raised Blood Pressure and Adverse Left Ventricular Remodeling in Adolescent Adiposity. (2019) (4)
- More knocks to the oxidation hypothesis for vascular disease? (2009) (4)
- The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study (2021) (4)
- Low grade inflammation is notably suppressed by conventional anti-inflammatory treatment: a randomised crossover trial (2004) (4)
- Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus. (2012) (4)
- Relation between birth weight and soluble markers of endothelial function in middle aged subjects (2006) (4)
- LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: A mendelian randomization analysis (2018) (4)
- Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study (2017) (4)
- Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study (2021) (4)
- Metabolic, Inflammatory, and Hemostatic Effects of a Low-Dose Continuous Combined HRT in Women With Type 2 Diabetes: Potentially Safer With Respect to Vascular Risk (2004) (4)
- Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease (2022) (4)
- Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial (2021) (4)
- An opportunity for prevention: associations between the Life's Essential 8 score and cardiovascular incidence using prospective data from UK Biobank. (2022) (4)
- P5306The comparison of the lipid profile in the population of Poland between 2004, 2006 and 2015 based on the results of the LIPIDOGRAM cohort studies (2017) (4)
- Association of Cardiac Biomarkers With Cardiovascular Outcomes in Patients With Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study (2022) (4)
- Metformin and weight loss in women with polycystic ovary syndrome (PCOS) (2002) (3)
- Normal levels of inflammatory markers in treated patients with familial hypercholesterolaemia: a cross-sectional study (2012) (3)
- Dose-response association between device-measured physical activity and incident dementia: a prospective study from UK Biobank (2021) (3)
- Socio‐economic differences in cardiovascular disease risk factor prevalence in people with type 2 diabetes in Scotland: a cross‐sectional study (2020) (3)
- Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study (2022) (3)
- The genomics of heart failure: design and rationale of the HERMES consortium (2021) (3)
- THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT) BIOMARKER PROGRAMME: LB1.3 (2011) (3)
- Rising Rates and Widening Socioeconomic Disparities in Diabetic Ketoacidosis in Type 1 Diabetes in Scotland: A Nationwide Retrospective Cohort Observational Study (2021) (3)
- Advancing a causal role of type 2 diabetes and its components in developing macro‐ and microvascular complications via genetic studies (2022) (3)
- Response to Comment on Hillis et al. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295–303 (2014) (3)
- Severe COVID‐19 in people 55 and older during the first year of the pandemic in Sweden (2022) (3)
- Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort (2021) (3)
- Ethnic Specific Obesity Cut-offs for Diabetes Risk: Cross-sectional Study of 489,690 UK Biobank Participants. (2014) (3)
- Weight loss-induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT). (2020) (3)
- High Density Lipoprotein pathway as a therapeutic target for coronary heart disease: individual participant meta-analysis in 28,597 individuals with 4197 coronary events (2020) (3)
- Diabetes: Which risk engines should be used to assess patients with diabetes? (2009) (3)
- The case for diabetes screening: ADDITION-Europe (2011) (3)
- Choice of medical therapy to lower triglycerides in those at risk of pancreatitis. (2013) (3)
- Understanding what we mean by the obesity paradox. (2018) (3)
- Research digest: heart failure in diabetes comes into focus. (2018) (3)
- Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes MellitusClinical Perspective (2017) (3)
- Inflammatory Cytokines and Cardiovascular Risk (2011) (3)
- Type 2 diabetes risks and determinants in second-generation migrants and mixed ethnicity people of South Asian and African Caribbean descent in the UK (2021) (3)
- Erratum: Obesity BMI and Mortality in UK Biobank: Revised Estimates Using Mendelian Randomization (2019) (3)
- Association and pathways between shift work and cardiovascular disease: a prospective cohort study of 238 661 participants from UK Biobank (2021) (3)
- Evaluating an Intervention to Increase Cereal Fiber Intake in Children: A Randomized Controlled Feasibility Trial (2020) (3)
- A POOLED SAFETY ANALYSIS OF OVER 6000 PATIENTS FROM DOUBLE-BLIND AND OPEN-LABEL EXTENSION STUDIES WITH EVOLOCUMAB (2016) (3)
- Associations of cord leptin and cord insulin with adiposity and blood pressure in White British and Pakistani children aged 4/5 years (2019) (3)
- Research digest: cardiac biomarkers for risk prediction. (2016) (3)
- 66-OR: Remission of Type 2 Diabetes for Two Years Is Associated with Full Recovery of Beta-Cell Functional Mass in the Diabetes Remission Clinical Trial (DiRECT) (2019) (3)
- W12-P-066 Insight into the nature of the CRP-coronary event association using mendelian randomisation (2005) (3)
- Optimisation of the ActWELL lifestyle intervention programme for women attending routine NHS breast screening clinics (2020) (3)
- Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21 (2022) (3)
- Potential role of statins and PPARs in rheumatoid arthritis (2006) (3)
- Statins and risk of incident diabetes – Authors' reply (2010) (3)
- Empagliflozin in Black Versus White Patients with Heart Failure: Analysis of EMPEROR-Pooled. (2022) (3)
- Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort (2022) (3)
- Erratum to A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial [BMC Pregnancy and Childbirth., 15, (2015), 111], DOI: 10.1186/s12884-015-0540-1 (2015) (3)
- Body mass index and heart failure risk: a cohort study in 1.5 million individuals and Mendelian randomisation analysis (2020) (3)
- Corrigendum to “Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study” [Neuroimage Clin. 2 (2013) 646–57] (2015) (3)
- HbA1c: a useful cardiovascular risk marker in those without diabetes? (2010) (3)
- Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now? (2005) (3)
- OP 12 Visceral adipose tissue activated macrophage content and inflammatory adipokine secretion is higher in pre-eclampsia than in healthy pregnancy (2017) (3)
- Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening (2021) (3)
- Research digest: weight loss to prevent and treat diabetes. (2016) (3)
- Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al (2019) (3)
- Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR‐Reduced (2022) (3)
- Range of Risk Factor Levels, Risk Control, and Temporal Trends for Nephropathy and End-stage Kidney Disease in Patients With Type 1 and Type 2 Diabetes. (2022) (3)
- Association Between Walking Pace and Stroke Incidence (2020) (3)
- Response by Lee et al to Letter Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)". (2021) (3)
- Polycystic Ovary Syndrome (2011) (2)
- The effects of tocilizumab treatment on lipids and inflammatory/prothrombotic markers in patients (pts) with rheumatoid arthritis (RA): data from the randomized, controlled, measure study (2012) (2)
- Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis. (2019) (2)
- Association of inflammatory mediators with premature atherosclerosis in rheumatoid arthritis and healthy controls: Comment on the article by Rho et al (2010) (2)
- Edinburgh Research Explorer Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes (2012) (2)
- Contributions of changes in physical activity, sedentary time, diet and body weight to changes in cardiometabolic risk (2021) (2)
- Hormone replacement therapy and C-reactive protein (1999) (2)
- PATIENTS WITH DIABETES AND PERIPHERAL ARTERIAL DISEASE: RESULTS FROM THE EXSCEL TRIAL (2019) (2)
- Testosterone replacement to prevent type 2 diabetes? Not just yet. (2021) (2)
- Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights. (2021) (2)
- Derivation and Validation of a 10-Year Risk Score for Symptomatic Abdominal Aortic Aneurysm (2021) (2)
- Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. (2016) (2)
- Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland (2022) (2)
- Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study (2014) (2)
- HIGH SERUM IMMUNOGLOBULIN G AND M LEVELS IMPROVE CARDIOVASCULAR RISK DISCRIMINATION IN HYPERTENSION: A NESTED CASE-CONTROL SUBSTUDY OF THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (2016) (2)
- Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. (2023) (2)
- Session 17: Promises of AMH (2013) (2)
- GDF15 and the beneficial actions of metformin in pre-diabetes (2019) (2)
- Metformin in type 1 diabetes: methods and baseline characteristics of the REMOVAL trial (2016) (2)
- Habitual dietary intake of obese pregnant women in the UK (2011) (2)
- Hormone Replacement Preparations and Hypertriglyceridemia in Women With NIDDM (1997) (2)
- 17-OR: ADA Presidents' Select Abstract: Effects of Tirzepatide vs. Insulin Glargine 100 U/mL on Kidney Outcomes in Participants with Type 2 Diabetes in SURPASS-4 (2022) (2)
- Research digest: progress in microvascular complications. (2018) (2)
- Comparative Incidence of Diabetes Following Hospital Admission for COVID-19 and Pneumonia: A Cohort Study. (2023) (2)
- Maternal obesity and ethnic groups: trends in 552 303 births over 13 years in England, UK (2010) (2)
- Blood markers and poor outcome after acute cerebrovascular disease: A prospective cohort study (2010) (2)
- Comment on Shah et al. Cardiovascular Complications and Mortality After Diabetes Diagnosis for South Asian and Chinese Patients: A Population-Based Cohort Study. Diabetes Care 2013;36:2670–2676 (2014) (2)
- QRISK2 validation by ethnic group (2013) (2)
- The Combination of Physical Activity and Sedentary Behaviors Modifies the Genetic Predisposition to Obesity (2019) (2)
- The effect of a lifestyle intervention in obese pregnant women on change in gestational metabolic profiles: findings form the UK Pregnancies Better Eating and Activity Trial (UPBEAT) RCT (2017) (2)
- More Evidence for 5-a-Day for Fruit and Vegetables and a Greater Need for Translating Dietary Research Evidence to Practice. (2021) (2)
- Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity (2019) (2)
- Erratum: A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial (2015) (2)
- Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials (2021) (2)
- ‘N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS’ [Eur Heart J (2013); 34(6):443–450] (2013) (2)
- Stressed hearts in children with obesity and diabetes: a cause for concern? (2011) (2)
- Research digest: hypoglycaemia and glucose variability. (2017) (2)
- Is there association between APOE e4 genotype and structural brain ageing phenotypes, and does that association increase in older age in UK Biobank? (N = 8,395) (2017) (2)
- The association between serum lipids and intraocular pressure in two large UK cohorts. (2022) (2)
- Pharmacological Management of Diabetes for Reducing Glucose Levels and Cardiovascular Disease Risk: What Evidence in South Asians? (2020) (2)
- Cardiovascular Outcomes Trials for Weight Loss Interventions: Another Tool for Cardiovascular Prevention? (2021) (2)
- FRI0431 EFFECT OF PHOSPHODIESTERASE 4 INHIBITION WITH APREMILAST ON BODY WEIGHT AND VASCULAR FUNCTION IN PSORIATIC ARTHRITIS – INITIAL RESULTS FROM THE IMMUNE METABOLIC ASSOCIATIONS IN PSORIATIC ARTHRITIS (IMAPA) STUDY (2019) (2)
- Ethnic differences in carotid intima media thickness and carotid-femoral pulse wave velocity are present in UK children (2011) (2)
- Metformin Therapy and Circulating NT-proBNP Levels: The CAMERA Trial (2016) (2)
- Obesity and mortality: summary of best evidence with explanations for the obesity paradox (2010) (2)
- Managing Cardiovascular Risk in Patients with Rheumatic Disease. (2022) (2)
- Tackling obesity in adult primary care. (2010) (2)
- Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management? (2022) (2)
- Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank (2022) (2)
- Statins are diabetogenic e Myth or reality ? (2012) (2)
- The association between driving time and unhealthy lifestyles: a cross-sectional, general population study of 386 493 UK Biobank participants. (2019) (2)
- Elevated glycoprotein acetyl levels in adolescence and early adulthood predict adverse cardiometabolic profiles and risk of metabolic syndrome in up to 10 year follow-up (2020) (2)
- A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases (2022) (2)
- Event rates in trials of patients with type 2 diabetes. (2010) (2)
- Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study (2021) (2)
- Prevention of Diabetes Macrovascular Complications and Heart Failure. (2021) (2)
- Body-mass index, abdominal adiposity, and cardiovascular risk – Authors' reply (2011) (2)
- No Effect of Levothyroxine on Hemoglobin in Older Adults With Subclinical Hypothyroidism: Pooled Results From 2 Randomized Controlled Trials (2022) (2)
- Abstract 814: CRP and Risk of Vascular Events in PROSPER (2006) (2)
- OP0221 TARGETED METABOLOMIC PROFILING AND PREDICTION OF CARDIOVASCULAR EVENTS: A PROSPECTIVE STUDY OF PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS (2)
- JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda (2016) (2)
- Association of Bio-Inflammatory Markers (CRP, IL-6) with Glucose Level In Obese T2DM Pakistani Patients (2018) (2)
- Treating chronic diseases without tackling excess adiposity promotes multimorbidity. (2022) (2)
- The REMOVAL trial: metformin reduces progression of mean carotid intima-media thickness (cIMT) in never smokers with type 1 diabetes (2018) (2)
- Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study (2021) (2)
- ect of a behavioural intervention in obese pregnant women ( the UPBEAT study ) : a multicentre , randomised controlled trial (2015) (2)
- Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort (2022) (2)
- SLEEP DURATION MAY NOT HAVE ANY EFFECT ON THE RISK OF STROKE: INSIGHTS FROM MENDELIAN RANDOMIZATION AND PROSPECTIVE COHORT STUDIES (2020) (2)
- Plasma ascorbic acid and risk of heart disease and cancer (2001) (2)
- The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis (2021) (2)
- High-throughput quantification of carboxymethyl lysine in serum and plasma using high-resolution accurate mass Orbitrap mass spectrometry (2019) (2)
- Association Between Device-Measured Physical Activity and Incident Heart Failure: A Prospective Cohort Study of 94 739 UK Biobank Participants (2022) (1)
- SP0012 How To Assess The CVD Risk in The Individual Patient? (2016) (1)
- Diabetes Remission Clinical Trial (DiRECT)—Plasma Liver Function Tests Reflect Change in Liver Fat Content in Early Type 2 Diabetes (2018) (1)
- Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT) (2022) (1)
- Vitamin D receptor FokI polymorphism in a Pakistani population with type 2 diabetes mellitus. (2020) (1)
- IGFBP-7 and Outcomes in Heart Failure With Reduced Ejection Fraction: Findings From DAPA-HF. (2022) (1)
- Pathogenesis of Atherosclerosis and Vascular Disease in Type 2 Diabetes (2008) (1)
- Evaluation of the causal effect of fibrinogen on incident coronary heart disease via Mendelian randomization (2018) (1)
- Research digest: more cardiovascular outcome trials in diabetes. (2017) (1)
- Effects of Canagli fl ozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes (2017) (1)
- Apoe-deficient mice are resistant to the development of collagen-induced arthritis (2010) (1)
- Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for b Cell Recovery Graphical (2018) (1)
- Plasma apolipoprotein A1 and birthweight (1998) (1)
- GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes. (2022) (1)
- Elevated adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: Does NT-proBNP explain the paradox? (2010) (1)
- Author Correction: Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease (2020) (1)
- Higher coronary heart disease mortality in South Asian compared with European men in the UK - prospective study (2004) (1)
- The effect of metformin on circulating amino acids in the Carotid Atherosclerosis: Metformin for insulin Resistance (CAMERA) trial reveals a novel effect on four amino acids (2015) (1)
- C reactive protein (2010) (1)
- Severe COVID-19 in People with Type 1 and Type 2 Diabetes in Sweden: A Nationwide Retrospective Case-Control Study (2021) (1)
- Prevalence of anti-nuclear autoantibodies (ANA) in the general Polish population - analysis of the influence of sex and age on the variability of ANA. (2021) (1)
- FRI0137 Risk factors for major adverse cardiovascular (CV) events (MACE) in rheumatoid arthritis (RA) patients treated with tocilizumab (TCZ) (2013) (1)
- Lipid Fractions and Contrasting Risks of Coronary Artery Disease and Diabetes: A Mendelian Randomization Study (2016) (1)
- The REMOVAL trial (Reducing with Metformin Vascular Adverse Lesions) in Type 1 diabetes: methods and baseline characteristics (2016) (1)
- OP68 How is overweight/obesity across the life course associated with levels of adipokines, inflammatory and endothelial markers at age 60–64 years? Findings from the 1946 birth cohort (2014) (1)
- SurgiCal Obesity Treatment Study (SCOTS): a prospective, observational cohort study on health and socioeconomic burden in treatment-seeking individuals with severe obesity in Scotland, UK (2021) (1)
- Type 2 diabetes risks and determinants in 2nd generation migrants and mixed ethnicity people of South Asian and African Caribbean descent in the UK (2019) (1)
- Protocol for a randomised controlled trial to investigate the effect of home- and gym-based resistance exercise training on glycaemic control, body composition and muscle strength (2020) (1)
- Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress (2022) (1)
- P5313The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis (2019) (1)
- High Circulating Triglycerides Are Most Commonly a Marker of Ectopic Fat Accumulation: Connecting the Clues to Advance Lifestyle Interventions. (2022) (1)
- Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease (2022) (1)
- Is Serum-Glutamylatransferase a Biomarker of Xenobiotics Which Are Conjugated by Glutathione? (2008) (1)
- Reducing cardiovascular risk in type 2 diabetes mellitus (2010) (1)
- Long-term efficacy of evolocumab in reducing lipids in EU subjects with and without type 2 diabetes: an analysis from the open-label extension OSLER studies (2016) (1)
- Statins and rheumatoid arthritis. Author's reply (2004) (1)
- Corrigendum to “Effects of aldosterone receptor blockade in patients with mild‐moderate heart failure taking a beta‐blocker” [European Journal of Heart Failure 9/4 (2007) 429–434] (2007) (1)
- Predictors of glucose intolerance (GI) in the West of Scotland Coronary Prevention Study (WOSCOPS) (2000) (1)
- Muscle protein synthesis and muscle/metabolic responses to resistance exercise training in South Asian and White European men (2021) (1)
- Excess diabetes in ethnic minorities - incidence and predictors (2011) (1)
- Cardiac arrhythmias and conduction abnormalities in patients with type 2 diabetes (2023) (1)
- Atherosclerosis in Rheumatoid Arthritis (2009) (1)
- Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study. (2022) (1)
- Role of the Metabolic Profile in Mediating the Relationship Between Body Mass Index and Left Ventricular Mass in Adolescents: Analysis of a Prospective Cohort Study (2020) (1)
- Association between cardiovascular risk factors and concurrent depressive symptoms in cardiometabolic disease: a cross-sectional study (2014) (1)
- Medical Research Council Hot Topic workshop report: Planning a UK Nutrition and Healthy Life Expectancy Trial (2021) (1)
- Publisher Correction: Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability (2021) (1)
- The common H202D variant in GDF-15 does not affect its bioactivity but can significantly interfere with measurement of its circulating levels (2022) (1)
- Thrombophilia (2013) (1)
- Excess mortality and cardiovascular disease risk in type 1 diabetes – Authors' reply (2019) (1)
- Thyroid disorders in pregnancy (2002) (1)
- Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021 (2023) (1)
- Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update (2022) (1)
- Role of vitamin D receptor (VDR) genetic polymorphism in onset of type 2 diabetes mellitus: A Review (2019) (1)
- Postnatal testing following gestational diabetes--Authors' reply. (2015) (1)
- The insulin resistance syndrome (2015) (1)
- Time course of normalisation of functional beta cell capacity in DiRECT after weight loss in type 2 diabetes (2020) (1)
- Publisher Correction: GDF15 mediates the effects of metformin on body weight and energy balance (2020) (1)
- The Association Between BMIMeasured Within a Year After Diagnosis of Type 2 Diabetes andMortality (2012) (1)
- Erratum to: Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013 (2016) (1)
- Maternal Obesity: Potential mechanisms contributing to gestational diabetes and pre-eclampsia in the obese woman (2012) (1)
- The hyperlipidaemia of normal pregnancy (1995) (1)
- The Menopause in Practice (2002) (1)
- Diabetes incidence in a high‐risk UK population at 7 years: linkage of the Prevention of Diabetes and Obesity in South Asians (PODOSA) trial to the Scottish Diabetes Register (2020) (1)
- 1123-P: Stress Cardiac Biomarkers and Adverse Cardiac Outcomes in the CANagliflozin CardioVascular Assessment Study (CANVAS) (2020) (1)
- Estimating cardiovascular disease-free life-years with the addition of semaglutide in people with type 2 diabetes using pooled data from SUSTAIN 6 and PIONEER 6 (2020) (1)
- Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK (2023) (1)
- Effect of Long-Term Treatment with Secukinumab on Cardio-Metabolic Profile in Patients with Active Ankylosing Spondylitis and Psoriatic Arthritis: Pooled 3 Year Analysis (2019) (1)
- Clinical characteristics and survival in patients with heart failure experiencing in hospital cardiac arrest (2022) (1)
- Care processes in people in remission from type 2 diabetes: A cohort study using the National Diabetes Audit (2022) (1)
- Sleep duration and risk markers for type 2 diabetes: a cross-sectional study in children aged 9–10 years (2015) (1)
- Sugar-sweetened beverages intake associates with all-cause mortality independently of other dietary and lifestyle factors and obesity (2019) (1)
- Impact of intentional weight loss in cardiometabolic disease: what we know about timing of benefits on differing outcomes? (2023) (1)
- Exploring the use of adjusted body mass index thresholds based on equivalent insulin resistance for defining overweight and obesity in UK South Asian children (2018) (1)
- 1123-P: Stress Cardiac Biomarkers and Adverse Cardiac Outcomes in the CANagliflozin CardioVascular Assessment Study (CANVAS) (2020) (1)
- Inhibitors of angiotensin-I-converting enzyme and risk of cancer (1998) (1)
- Reply to: Prognostic implications of vitamin D in patients with COVID-19 (2020) (1)
- Intensive glucose control and cardiovascular outcomes – Authors' reply (2009) (1)
- The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes. (2016) (1)
- Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2020) (1)
- RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH THE INTERLEUKIN-6 RECEPTOR INHIBITOR TOCILIZUMAB (2012) (1)
- LB005KIDNEY IMPLICATIONS OF THE INITIAL EGFR RESPONSE TO SGLT2 INHIBITION WITH EMPAGLIFLOZIN: THE ‘EGFR DIP’ IN EMPA-REG OUTCOME (2020) (1)
- A longitudinal study of the relationship between lipid, haemostatic and hormonal changes during normal human pregnancy (1998) (1)
- Type-2 diabetes patients at high risk for cardiovascular events: time to challenge the 'metformin-always first' paradigm. (2021) (1)
- Fatness, faltering metabolism and fecundity: an expanding challenge in reproductive medicine (2009) (1)
- The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale (2020) (1)
- Ankle brachial index vs metabolic syndrome for risk prediction – Authors' reply (2008) (1)
- Tackling obesity in adults in primary care (2010) (1)
- Quality of included studies (2011) (1)
- Improvements in Liver Enzymes with Empagliflozin in the EMPA-REG OUTCOME Trial (2018) (1)
- Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults (2017) (1)
- Endothelial function measures: not for clinical prime time? (2015) (1)
- The Effect of Transdermal HRT on Insulin Sensitivity in Women with Type 2 Diabetes Mellitus (1999) (1)
- Do risk factors measured 20 years previously predict and explain ethnic differences in HbA1c among non-diabetic British South Asians, African Caribbeans and Europeans? (2013) (1)
- Plasma leptin levels and coronary heart disease - Response (2002) (1)
- Vitamin D testing – Authors' reply (2012) (1)
- Response by Welsh et al to Letter Regarding the Article "Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease". (2019) (1)
- Rheumatoid arthritis: Testing the inflammation–insulin resistance link in clinical trials (2013) (1)
- 15262 Cardio-metabolic effects of long-term treatment with secukinumab in psoriatic arthritis and ankylosing spondylitis patients: Pooled 3 year analysis (2020) (1)
- Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF). (2022) (1)
- Metabolic syndrome and diabetes mellitus - Response. (2004) (1)
- Risk scoring in secondary prevention: a basis for informed clinical decisions in the context of ever-expanding treatments. (2022) (1)
- COVID-19 infection and subsequent thromboembolism: A self-controlled case series analysis of a population cohort (2021) (1)
- Effects of Canagli fl ozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes (2017) (1)
- COVID-19 Disease in People with Diabetes in Scotland: Incidence, Severity and Risk Stratification Using Matched Case-Control and Prospective Cohort Studies (2020) (1)
- Do statins reduce the risk for diabetes by improving exercise capacity? Response (2001) (1)
- Role of Remdesivir in COVID-19 (2021) (1)
- Coronary disease. (1969) (1)
- Royal Medico-Chirurgical Society of Glasgow, Annual Research Prize Night, 1 March 2012 (2012) (1)
- Evidence for the use of metformin in women with polycystic ovary syndrome (2003) (1)
- High sensitivity C-reactive protein in cardiovascular disease and type 2 diabetes: evidence for a clinical role? (2006) (1)
- Large scale trans-ethnic meta-analyses identify novel rare and common variants associated with blood pressure and hypertension (2016) (1)
- Lipid metabolism. (2013) (1)
- Social media and political participation: BBC World Service and the Arabic Spring (2017) (1)
- Correction: Which Circulating Antioxidant Vitamins Are Confounded by Socioeconomic Deprivation? The MIDSPAN Family Study (2010) (1)
- Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies (2015) (1)
- Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank (2022) (1)
- Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (2022) (1)
- Relationship of carotenoid and vitamins A and E with the acute inflammatory response in acute alcoholic hepatitis (2001) (1)
- Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby) (2023) (1)
- Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised controlled trial in primary care (2016) (1)
- Personalised blood pressure ranges in type 2 diabetes? (2018) (1)
- Efficacy of one year of treatment with the PCSK9 inhibitor evolocumab (AMG 145) in 4,802 subjects with or without type 2 diabetes (2015) (1)
- LENS - a clinical trial embedded in routine clinical practice to reduce the burden of diabetic eye disease (2017) (1)
- Risk stratification for diabetic eye screening. Reply to Stratton I. M. and Aldington S. J. [letter] (2013) (1)
- Comprar ABC of Obesity | Naveed Sattar | 9781405136747 | Blackwell Publishing (2007) (1)
- Young onset diabetes in Asian Indians is associated with lower measured and genetically determined beta-cell function: an INSPIRED study (2021) (1)
- Don’t rush into testing and treating children (2012) (1)
- Variation in the SLC 23 A 1 genedoesnot influencecardiometabolicoutcomes to the extent expected given its association with L-ascorbic acid 1 – 4 (2014) (1)
- COVID-19 in people aged 18–64 in Sweden in the first year of the pandemic: Key factors for severe disease and death (2022) (1)
- Muscle disorders111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study (2012) (1)
- 30-OR: Empagliflozin Delays Need for Insulin Initiation in Patients with Type 2 Diabetes and Cardiovascular Disease: Findings from EMPA-REG OUTCOME (2020) (1)
- Managing weight and glycaemic targets in people with type 2 diabetes—How far have we come? (2022) (1)
- Prawn sandwiches, red herrings and abdominal pregnancy. (1997) (1)
- Does the association between physical capability and mortality differ by deprivation? Findings from the UK Biobank population-based cohort study (2020) (1)
- Erratum: Dietary lipids and vascular function: UK Food Standards Agency workshop report (British Journal of Nutrition (2004) vol.91 (3) (491)) (2004) (1)
- Serum Antioxidant Activity after Myocardial Infarction (1998) (1)
- Diabetes in the West of Scotland Coronary Prevention Study Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart (2003) (0)
- risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: additive value of nt-probnp (2015) (0)
- A review of current key guidelines for managing high risk patients with diabetes and heart failure and future prospects. (2023) (0)
- Prospective Associations Of Objectively-measured Physical Activity And Cardiovascular Risk Factors During Early Adolescence: 1348 (2011) (0)
- Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland. (2018) (0)
- P18 Fatty acid desaturase expression and activity in adipose tissue in pregnancy; relation to preeclampsia and markers of maternal insulin resistance and inflammation (2010) (0)
- Author Correction: Associations of social and economic and pregnancy exposures with blood pressure in UK White British and Pakistani children age 4/5 (2018) (0)
- Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2021) (0)
- Faculty Opinions recommendation of Intensive glucose control and macrovascular outcomes in type 2 diabetes. (2014) (0)
- Abstract 11459: Mitochondrial Metabolites Predict Cardiovascular Outcomes and Heart Failure in Individuals with Type 2 Diabetes Mellitus: An Exscel Biomarker Substudy (2021) (0)
- Systematic inflammatory response and survival in advanced cancers (2001) (0)
- 490-P: Renal Effects of Metformin in Type 1 Diabetes (T1D): The REMOVAL Trial (2020) (0)
- Statins should be first line in majority with hypertriglyceridaemia (2017) (0)
- Adiponectin and Coronary Heart Disease (2006) (0)
- Using genetics to uncouple higher adiposity from its adverse metabolic effects and understand its role in metabolic and non-metabolic disease. (2021) (0)
- OPINION Focus on fruits and vegetables to reduce cardiovascular disease and all-cause mortality (2013) (0)
- INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-7 PREDICTS CARDIOVASCULAR AND RENAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: THE CREDENCE TRIAL (2022) (0)
- LOW BIRTHWEIGHT AND LATER RENAL FUNCTION - THE ROLE OF ADULTHOOD OBESITY. RESULTS FROM THE 1946 BRITISH BIRTH COHORT STUDY (2013) (0)
- O10 The association of high sensitivity troponin levels with subsequent cardiovascular mortality in an inflammatory arthritis cohort: results from the Norfolk arthritis register (2018) (0)
- Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status. (2022) (0)
- Reply (2011) (0)
- 肝酵素,非アルコール性脂肪性肝疾患と心血管疾患の発症--叙述的総説と前向きデータの臨床的展望 (2011) (0)
- THE ROLE OF VITAMIN D IN TOTAL AORTIC STIFFNESS, AND REGIONAL AORTIC ZONES MEASURED BY MAGNETIC RESONANCE IMAGING, IN MEN AT DIFFERING CORONARY RISK: 5C.09 (2011) (0)
- Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross sectional study of young adult males and females (2013) (0)
- Development of a Complex Intervention To Improve Outcome in Obese Pregnancies; the UPBEAT Protocol (2011) (0)
- Metformin does not reduce the elevated C-reactive protein observed in obese women with PCOS (2002) (0)
- Research digest: genetics in cardiometabolic disease. (2018) (0)
- O1-2.4 Hypertensive disorders of pregnancy and offspring vascular, inflammatory and lipid outcomes in childhood: findings from the Avon Longitudinal Study of Parents and Children (2011) (0)
- Thrombophilia and pregnancy complications Scott M Nelson, Ian A Greer (2006) (0)
- 1781-P: Remission of Type 2 Diabetes over 2 Years Normalizes Morphology of the Whole Pancreas (2020) (0)
- Pregnancy and programming (2006) (0)
- Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT (2020) (0)
- High sensitivity cardiac troponin T and N-terminal pro-BNP predict cardiovascular events and death in patients with type 2 diabetes mellitus (2013) (0)
- 45Association of types of dietary fats and all-cause and cause-specific mortality: a prospective cohort study and meta-analysis of prospective studies with 1,148,117 participants (2019) (0)
- Clinical outcomes with the LMWH, tinzaparin in pregnancy: an international retrospective audit (2010) (0)
- PROSTACYCLIN PRODUCTION BY UMBILICAL ARTERIES FROM PREGNANCIES COMPLICATED BY SEVERE PREGNANCY INDUCED HYPERTENSION (1987) (0)
- The role of nitric oxide in the maintenance of human pregnancy (1998) (0)
- Timing of initiation of hormone replacement therapy and cognitive function (2016) (0)
- Resistant to Suppression by Insulin Than in Healthy Pregnancy In Preeclampsia, Maternal Third Trimester Subcutaneous Adipocyte Lipolysis Is More (2015) (0)
- Diagnostic aspects of pulmonary embolism (2004) (0)
- The Vascular Pathophysiology of Pre-Eclampsia (1992) (0)
- Influence of Adiposity on Insulin Resistance and Glycemia Markers Among U.K. Children of South Asian, Black African-Caribbea n, and White (2013) (0)
- La atenuación de la vasoconstricción inducida por la endotelina 1 mediante 17 betaestradiol no se mantiene durante el tratamiento a largo plazo en mujeres posmenopáusicas con coronariopatía (2001) (0)
- Correction to: Protocol for a randomised controlled trial to investigate the effect of home- and gym-based resistance exercise training on glycaemic control, body composition and muscle strength (2020) (0)
- DC122241 2779..2786 (2013) (0)
- Association of GDF15 Levels with Body Mass Index and Endocrine Status in β-Thalassaemia. (2023) (0)
- Disparities in PCSK9 Initiation Among US Veterans with Peripheral Arterial Disease or Cerebrovascular Disease (2023) (0)
- Author response: Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation (2021) (0)
- Identifying the Biomarker Profile of Pre-Frail and Frail People: A Cross-Sectional Analysis from UK Biobank (2023) (0)
- Estimating individual lifetime risk of incident cardiovascular events in adults with type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2). (2022) (0)
- Associations of grip strength and walking pace with mortality in stroke survivors: a prospective study from UK Biobank. (2023) (0)
- A multisystem, cardio-renal investigation of post-COVID-19 illness (2022) (0)
- Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease (2019) (0)
- Exploring the underlying mechanisms linking adiposity and cardiovascular disease: A prospective cohort study of 404,332 UK Biobank participants. (2023) (0)
- Response to Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care 2022;45:634–641 (2023) (0)
- Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications (2023) (0)
- Body composition and lung cancer-associated cachexia in TRACERx (2023) (0)
- The burden of coronary revascularization associated with lipoprotein(a) in patients with atherosclerotic cardiovascular disease: data from the UK Biobank (2022) (0)
- Pre-conception maternal erythrocyte saturated to unsaturated fatty acid ratio predicts pregnancy after natural cycle frozen embryo transfer (2018) (0)
- CA125 IN PATIENTS WITH HFREF AND THE EFFECT OF DAPAGLIFLOZIN: INSIGHTS FROM DAPA-HF (2023) (0)
- Family history of diabetes and risk of SARS‐COV‐2 in UK Biobank: A prospective cohort study (2021) (0)
- GDF15 mediates the effects of metformin on body weight and energy balance (2019) (0)
- Author Correction: Genetic analysis of over half a million people characterises C-reactive protein loci (2022) (0)
- Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes (2018) (0)
- Espresso time? (2018) (0)
- 3 Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) trial MRI sub-study (2021) (0)
- Post-COVID-19 illness trajectory: a multisystem investigation. (2021) (0)
- ORIGINAL RESEARCH ARTICLE Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease (2022) (0)
- Response by Tabák et al to Letters Regarding Article, "Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study". (2023) (0)
- Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol (2022) (0)
- Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) (2022) (0)
- Weight loss, visit-to-visit body weight variability and cognitive function in older individuals (2023) (0)
- University of Birmingham Evaluating an intervention to increase cereal fiber intake in children (2021) (0)
- Beta Cell Function, Hepatic Insulin Clearance, and Insulin Sensitivity in South Asian and Nordic Women after Gestational Diabetes Mellitus. (2022) (0)
- Menopausal hot flashing and endothelial function in two vascular beds: findings from a cross-sectional study of postmenopausal women. (2019) (0)
- The time‐varying cardiovascular benefits of glucagon‐like peptide‐1 receptor agonist therapy in patients with type 2 diabetes mellitus: Evidence from large multinational trials (2022) (0)
- Edinburgh Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012–2014): population-based observational study (2018) (0)
- MULTIPLE CARDIAC BIOMARKERS TO OPTIMISE PREDICTION OF CARDIOVASCULAR EVENTS IN THE GENERAL POPULATION (2023) (0)
- Grip strength and diabetes in black , South Asian , and white adults 7 8 (2017) (0)
- XBP1 expression in pancreatic islet cells is associated with poor glycaemic control across ancestries especially in young non-obese onset diabetes (2023) (0)
- Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis (2022) (0)
- Dietary Weight-Management for Type 2 Diabetes Remissions in South Asians: The SouTh AsiaN Diabetes Remission FeasiBilitY And Randomised Trial (STANDby) (2022) (0)
- Correction to: Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function (2022) (0)
- Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies. (2023) (0)
- P3823Body mass index or waist and hip circumference as predictors of outcome in the UK biobank (2019) (0)
- Abstract 11692: High-Sensitivity Cardiac Troponin and the Efficacy of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial (2021) (0)
- Reply to letter of Davie et al. regarding the article: "Vitamin D concentrations and COVID-19 infection in UK Biobank" (Hastie et al.). (2021) (0)
- FRI0142 Aggressive dmard therapy elevates hdl-cholesterol and lowers the atherogenic index in the taser study (2013) (0)
- Associations Between HbA1c Across the Normal Range, Diagnosed, and Undiagnosed Diabetes and Retinal Layer Thickness in UK Biobank Cohort (2023) (0)
- OP0192 PSORIATIC ARTHRITIS IS ASSOCIATED WITH A METABOLICALLY ADVERSE BODY COMPOSITION PROFILE PREDICTIVE OF GREATER CHD AND TYPE 2 DIABETES RISK – MRI FINDINGS FROM THE IMAPA AND UK BIOBANK STUDIES (2020) (0)
- Role of vitamin D receptor (VDR) genetic polymorphism in onset of type 2 diabetes mellitus (2019) (0)
- Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study (2023) (0)
- Association of vitamin D receptor genetic polymorphism to the type 2 diabetes mellitus in local populaion (2016) (0)
- Different adiposity measures across sex, age, ethnicity, and COVID-19 (2020) (0)
- Insulin Resistance in young obese females with and without Polycystic Ovary Syndrome. (2022) (0)
- Oxidative stress level among females with Type 2 Diabetes Mellitus with & without Polycystic Ovarian Syndrome. (2022) (0)
- Lifestyle intervention in obese pregnancy and cardiac remodelling in 3-year olds: children of the UPBEAT RCT (2022) (0)
- The association of lipoprotein(a) with mace including coronary revascularisations in patients with atherosclerotic cardiovascular disease: Data from UK Biobank (2022) (0)
- 1.4-O8Progression to diabetes in Indian and Pakistani adults with impaired glycaemia in central Scotland: follow-up by record linkage in the PODOSA trial (Prevention of Diabetes & Obesity in South Asians) (2018) (0)
- Edinburgh Research Explorer Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes (2016) (0)
- Edinburgh Research Explorer Predicted impact of extending the screening interval for diabetic retinopathy (2013) (0)
- University of Dundee The effect of a programme to improve men's sedentary time and physical activity Wyke, (2019) (0)
- Augmenting clinical risk prediction of cardiovascular disease through protein and epigenetic biomarkers (2022) (0)
- Empagliflozin facilitates sustained insulin dose reductions in patients with type 2 diabetes and cardiovascular disease: the EMPA-REG OUTCOME trial (2021) (0)
- Testing for association between exonic glucagon‐like peptide 1 receptor mutation with physical and brain health traits in UK Biobank (2022) (0)
- Concise report Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity – a cross-sectional study (2020) (0)
- South Asians prioritise muscle proteolysis over lipolysis in the fasted state: this may contribute to their predisposition to insulin resistance (2016) (0)
- Vascular adaptations to obesity in childhood (2011) (0)
- Estimating Cardiovascular Impacts of Drugs for Psoriatic Disease: A Long Way to Go. (2021) (0)
- P2.17-22 Cardiac Biomarkers in CART Study (CARdiac Toxicity in Lung Cancer Patients After Chemo-Radiotherapy). (2018) (0)
- P27 Changes in cognitive function with the menopausal transition: a longitudinal study in ALSPAC women (2019) (0)
- Lipid Lowering in “Very High Risk” Patients Undergoing Coronary Artery Bypass Surgery and Its Projected Reduction in Risk for Recurrent Vascular Events: A Monte Carlo Stepwise Simulation Approach (2022) (0)
- Response to 'interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders' by Hassan et al. (2014) (0)
- Dose-response associations of cardiorespiratory fitness with all-cause mortality, and also cancer, cardiovascular and respiratory disease mortality and incidence: the UK Biobank cohort study (2019) (0)
- Association Between Walking Pace and Incident Type 2 Diabetes by Adiposity Levels - A Prospective Cohort Study from The UK Biobank. (2023) (0)
- End-stage renal disease and survival in people with diabetes (2016) (0)
- Reply (Need for a Three-Focused Approach to Nonalcoholic Fatty Liver Disease) (2011) (0)
- Abstract 17498: Prognostic Importance of Novel Cardiac and Renal Biomarkers in Patients With Heart Failure, Reduced Ejection Fraction and Anemia (2014) (0)
- Association of maternal lipid levels with birth weight and cord blood insulin: a Bayesian network analysis (2022) (0)
- Edinburgh Explorer The Effect of Dapagliflozin on Glycaemic Control and other Cardiovascular Disease Risk factors in type 2 diabetes mellitus: a real-world observational study (2019) (0)
- (2018). Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking. Diabetes Care , [dc172508]. (2018) (0)
- High prevalence and significant ethnic differences in actionable HbA1C after gestational diabetes mellitus in women living in Norway (2022) (0)
- Author response for "Diabetes drugs and stroke risk: intensive vs. conventional glucose‐lowering strategies, and implications of recent cardiovascular outcome trials" (2019) (0)
- MO481KIDNEY FUNCTION MEASURES AND THE RISK OF CANCER INCIDENCE, CANCER DEATH AND ALL-CAUSE MORTALITY* (2021) (0)
- Circulation: Cardiovascular Interventions. (2016) (0)
- Authors’ reply to Colquhoun and Buchinsky (2017) (0)
- Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes (2022) (0)
- Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure (2020) (0)
- between outdoor temperature and disease risk factors in older people. (2016) (0)
- Insight into the nature of the URF-uukunary event association using mendelian randomisation (2005) (0)
- GROWTH DIFFERENTIATION FACTOR-15, CLINICAL OUTCOMES, AND THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: INSIGHTS FROM THE DAPA-HF TRIAL (2023) (0)
- Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps (2018) (0)
- Interview: Naveed Sattar (2022) (0)
- Left-Sided Degenerative Valvular Heart Disease in Type 1 and Type 2 Diabetes (2022) (0)
- Changes in women’s physical function in mid-life by reproductive age and hormones: a longitudinal study (2022) (0)
- Chapter 9 ApoE genotype , plasma cholesterol , and cancer : A Mendelian randomization study (2010) (0)
- Current management and screening of peripheral and coronary artery disease in people with diabetes mellitus in Europe. The PADDIA/CADDIA survey. (2022) (0)
- PROTEOMIC MARKERS OF CARDIAC FIBROSIS AND ENDOTHELIAL FUNCTION ASSOCIATED WITH HEART FAILURE IN PATIENTS WITH DIABETES: AN EXSCEL BIOMARKER SUB-STUDY (2023) (0)
- Publisher Correction: GDF15 mediates the effects of metformin on body weight and energy balance (2020) (0)
- Abstract 172: Disparities In Pcsk9 Inhibitor Initiation Among Patients With Peripheral Arterial Disease Or Cerebrovascular Disease: A Cohort Study Of 500,000 Patients With Atherosclerotic Vascular Disease. (2022) (0)
- Gestational diabetes in women with obesity; an analysis of clinical history and simple clinical/anthropometric measures (2022) (0)
- Cardiovascular and kidney implications of the initial response in estimated glomerular filtration rate to sodium glucose cotransporter-2 inhibition with empagliflozin: the ‘eGFR dip’ in EMPA-REG OUTCOME (2021) (0)
- Edinburgh Research Explorer Association of N-Terminal Pro-Brain Natriuretic Peptide with Cognitive Function and Depression in Elderly People with Type 2 Diabetes (2018) (0)
- Ameta-analysis of 120 246 individuals identi fi es 18 new loci for fi brinogen concentration (2016) (0)
- Implementation of proteomic biomarkers: making it work PERSPECTIVE (2012) (0)
- Investigating the causal effect of smoking on hay fever and asthma: a Mendelian randomization meta-analysis in the CARTA consortium (2017) (0)
- Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization (2022) (0)
- Response to Letter Regarding Article, “Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis” (2007) (0)
- The UK Pregnancies Better Eating and Activity Trial phase 1 – development phase: involvement of patients and providers in development of the UK Pregnancies Better Eating and Activity Trial intervention (2017) (0)
- Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study (2023) (0)
- POS1068 Cardiac biomarkers are associated with the development of cardiovascular events in patients with psoriatic arthritis and psoriasis (2021) (0)
- Muscle protein synthesis and muscle/metabolic responses to resistance exercise training in South Asian and White European men (2022) (0)
- High-Sensitivity Cardiac Troponin Concentration and Risk of First-EverCardiovascular Outcomes in154,052 Participants (0)
- Effects of tirzepatide versus insulin glargine 100U/ml on kidney outcomes in people with type 2 diabetes in SURPASS-4 (2023) (0)
- Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19 (2023) (0)
- Outcomes related to IGFBP-7 in patients with heart failure and reduced ejection fraction and effects of dapagliflozin: findings from DAPA-HF (2022) (0)
- Author response for "Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales" (2021) (0)
- Trends in Prescriptions of Cardioprotective Diabetic Agents After Coronary Artery Bypass Grafting Among U.S. Veterans. (2022) (0)
- P2-330 Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: a cross-sectional analysis in the Avon Longitudinal Study of Parents and Children (ALSPAC) (2011) (0)
- Relationship between endothelin-1, heart failure with reduced ejection fraction and dapagliflozin: findings from DAPA-HF (2022) (0)
- Reduction of ethnic inequalities in birthweight: a public health paradox (2012) (0)
- Effect of tocilizumab on cardiac biomarkers high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis: Post hoc analysis of a randomised controlled trial (2016) (0)
- Author response for "Weight loss induced increase in fasting ghrelin concentration is a predictor of weight regain: evidence from the Diabetes Remission Clinical Trial" (2020) (0)
- OP30 Are the Associations Between Adiposity, Insulin Resistance and Circulating Glucose Concentrations in Childhood Influenced by Ethnicity? Evidence from the Child Heart and Health Study in England (CHASE) (2012) (0)
- Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013–2018 (2022) (0)
- 50 Ischaemia and No Obstructive Coronary Artery Disease (INOCA): prevalence and predictors of coronary vasomotion disorders (2019) (0)
- 1844-P: Long-Term Remission of Type 2 Diabetes after Weight Loss Requires Effective Clearance of Hepatic VLDL-TG and Maintenance of Low Intrapancreatic Fat (2019) (0)
- Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF. (2023) (0)
- Socioeconomic Status and the Cerebellar Grey Matter Volume. Data from a Well-Characterised Population Sample (2013) (0)
- The Relationship Between Metabolic Risk Factors and Incident Cardiovascular Disease in Europeans, South Asians, and African Caribbeans A Prospective Population-Based Study (2013) (0)
- 1461-P: Cardiac Troponin T and Troponin I and Incident Diabetes in the General Population: Generation Scotland Scottish Family Health Study (2019) (0)
- Improving prevention strategies for cardiometabolic disease (2020) (0)
- Multi-omics Diagnosis of Psoriatic Arthritis (2022) (0)
- University of Dundee Pathophysiology of LV Remodeling in Survivors of STEMI Inflammation, Remote Myocardium, and Prognosis Carrick, (2016) (0)
- Correction to: A novel approach to increasing community capacity for weight management a volunteer-delivered programme (ActWELL) initiated within breast screening clinics: a randomised controlled trial (2022) (0)
- Cardiovascular health in the menopause transition: a longitudinal study of up to 3892 women with up to four repeated measures of risk factors (2022) (0)
- Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study (2022) (0)
- Mendelian randomisation and disease risk estimates for C-reactive protein (CRP) (2005) (0)
- Poster session 3 (2001) (0)
- Poster Session 3 (2012) (0)
- 5 Effect of remote ischaemic preconditioning on coronary artery function in patients with stable coronary artery disease (2018) (0)
- Deleterious effect of non-esterified free fatty acids (NEFAs) on resistance artery endothelial function (2002) (0)
- Faculty Opinions recommendation of Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. (2014) (0)
- The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes (2021) (0)
- Putative miRNA biomarkers of insulin resistance and the effect of metformin: data from the CAMERA trial (2017) (0)
- Fibrinolytic markers in pregnancy: relationship to pertubations in lipoprotein levels (1995) (0)
- Association Between Low-Density Lipoprotein Cholesterol – Lowering Genetic Variants and Risk of Type 2 Diabetes AMeta-analysis (2016) (0)
- Review for "The Dual GIP and GLP ‐1 Receptor Agonist Tirzepatide Improves Cardiovascular Risk Biomarkers in Patients with Type 2 Diabetes: a Post‐Hoc Analysis" (2021) (0)
- THE LAMENTABLE SCARCITY OF TRIALS OF MEDICINES FOR CONGENITAL HEART DISEASE: A SYSTEMATIC REVIEW OF THE LITERATURE. (2023) (0)
- Growth hormone replacement reduces circulating inflammatory markers, blood pressure and large artery compliance but does not affect resistance artery function in adult hypopituitary patients (2004) (0)
- Effects of metformin on obese women with Polycystic Ovary Syndrome (PCOS) (1998) (0)
- BRITISH PROSTATE GROUP: SPRING MEETING AND TRAINING COURSE 2003 (2004) (0)
- Heart failure: now centre-stage in diabetes. (2022) (0)
- 1975-P: Effects of Bariatric Surgery on the Incidence of Heart Failure and Atrial Fibrillation in Patients with Type 2 Diabetes and Obesity: A Nationwide, Matched, Observational Cohort Study (2020) (0)
- Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter] (2023) (0)
- Metformin: framed again for a crime it didn't commit? (2018) (0)
- Response by Welsh et al to Letter Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease". (2019) (0)
- Pravastatin and glucose intolerance: Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study (2000) (0)
- Statins and diabetes: What are the connections? (2023) (0)
- Abstract 11537: Progress Towards a Proteomic Surrogate Endpoint for Cardiovascular Outcomes (2021) (0)
- University of Dundee Glycaemic control trends in people with Type 1 diabetes in Scotland 2004-2016 Scottish Diabetes Research Network Epidemiology Group; Mair, Colette; Wulaningsih, (2019) (0)
- OP-CLCH210193 1351..1360 (2021) (0)
- Research digest: topical trials in thyroid disease. (2017) (0)
- Abstract 18108: A Rapid Effect of Rosuvastatin and Atorvastatin on Myocardial Damage, as Measured by High Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular Disease, Results From the RADAR Substudy (2017) (0)
- M. (2017). Programming of Adiposity in Childhood and Adolescence: Associations With Birth Weight and Cord Blood (2017) (0)
- 2 Coronary flow reserve and index of microvascular resistance in acute stemi (2016) (0)
- The UK Pregnancies Better Eating and Activity trial: phase 2 – pilot trial (2017) (0)
- Original Contribution Apolipoprotein E Genotype, Plasma Cholesterol, and Cancer: A Mendelian Randomization Study (2009) (0)
- Research digest: assessment and risks of obesity. (2018) (0)
- SYSTEMATIC REVIEW OF PREVALENT AND INCIDENT HEART FAILURE IN CARDIOVASCULAR OUTCOME TRIALS OF PATIENTS WITH TYPE 2 DIABETES (2018) (0)
- The cardiac toxicity CMR Study in patients with lung cancer treated with chemo-radiotherapy: The CART study- a semi quantitative analysis of the myocardial perfusion index (2016) (0)
- Primary care recorded NAFLD and the risk of incident MI and stroke: Findings from analyses of 18 million patients in the UK, the Netherlands, Spain, and Italy (2018) (0)
- The variable number of tandem repeat polymorphism in the NOS3 gene is associated with arterial compliance and insulin resistance in coronary artery disease (2006) (0)
- A gene gene interaction of single nucleotide polymorphisms within two oxidative stress genes affects arterial compliance in patients with coronary artery disease (2006) (0)
- SEnsitivity and specificity of biochemical screening for familial hypercholesterolaemia in childhood: avon longitudinal study of parents and children (ALSPAC). (2017) (0)
- Treatment of severe hypertriglyceridaemia. (2014) (0)
- Re: Rearranging the deck chairs on the Titanic (2017) (0)
- COPYRIGHT MEDINEWS (DIABETES) LIMITED REPRODUCTION PROHIBITED (2003) (0)
- 1118-P: Validation of the PromarkerD Test for Predicting Renal Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS) (2020) (0)
- CURRENT SMOKING, MICROVASCULAR PATHOLOGY AND ADVERSE OUTCOME AFTER ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: NEW PATHOPHYSIOLOGICAL INSIGHTS (2017) (0)
- 132-LB: Implications of Initial EGFR Response to Empagliflozin Treatment Effects (2020) (0)
- Effect of inflammatory response on trace element and vitamin status - Reply (2001) (0)
- Diagnosing diabetes in patients with cardiovascular disease: why HbA1c should be the preferred test in the majority of patients and why the OGTT fails to (2016) (0)
- 409Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies (2019) (0)
- SU87PCSK9 GENETIC VARIANTS, LIFE-LONG LOWERING OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL, AND COGNITIVE ABILITIES (2019) (0)
- Mirjafari, Hoda et al. (2014) N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results (2014) (0)
- Abstract 14849: Lifetime Benefit of Empagliflozin in Extending Survival Free From Insulin Initiation in Type 2 Diabetes and Cardiovascular Disease: An Actuarial Analysis of EMPA-REG OUTCOME (2020) (0)
- To ApoB or Not to ApoB: New Arguments, but Basis for Widespread Implementation Remains Elusive. (2022) (0)
- C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Epidemiology (2007) (0)
- Comprar Assessment of Human Reproductive Function | Naveed Sattar | 9781573317207 | Wiley (2009) (0)
- P2.05-047 Feasibility Study: Assessment of RT Dose Using Cardiac MRI Contouring Methodology on Retrospective Lung Planning CT Scans (2017) (0)
- Reply to the letter to the editor regarding the article "Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population". (2019) (0)
- 1 Subsequent Event Risk in Individuals with Established Coronary Heart Disease : Design and Rationale of the GENIUS-CHD Consortium Running title : (2019) (0)
- Food, fatness and facts: the need for a standard message (2008) (0)
- Author reply: Which risk engines are best to assess CVD risk in diabetes? (2010) (0)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (0)
- P l^y^^f | ^ E For the full versions of these articles see bmj.com (2016) (0)
- Pravastatin and glucose intolerance (2000) (0)
- A COMPREHENSIVE COMPARISON OF THE PATHOPHYSIOLOGICAL AND PROGNOSTIC SIGNIFICANCE OF CORONARY FLOW RESERVE AND THE INDEX OF MICROVASCULAR RESISTANCE IN THE CULPRIT CORONARY ARTERY OF PATIENTS WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION (2016) (0)
- Abnormalities of vascular function and fibrinolysis in young women with polycystic ovary syndrome (2002) (0)
- Non-alcoholic fatty liver disease and relative risk of incident steatohepatitis, cirrhosis and hepatocellular carcinoma events in four European primary care databases (2018) (0)
- 456-P: The REMOVAL Trial: Effect of Metformin on Markers of Cardiometabolic Risk in Patients with Type 1 Diabetes (2019) (0)
- Y chromosome consomic strains and metabolic syndrome in the stroke prone spontaneously hypertensive rat (2002) (0)
- Editorial: Lipid Changes With Different Antiinflammatory Regimens in Rheumatoid Arthritis: Developing a Pragmatic Approach to Complex Data (2016) (0)
- Baseline Predictors and Influence of Early Weight Loss during an Intensive Weight Management Programme on Remission of Type 2 Diabetes after 12 Months—Post-Hoc Analysis of the Diabetes Remission Clinical Trial (DiRECT) (2018) (0)
- Research Digest (2005) (0)
- Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial (2023) (0)
- Abstract 14506: Effect of Evolocumab on Lipoprotein Profiles in Patients With and Without Diabetes (2016) (0)
- Association between socio-economic status and fatty acid status in women of child-bearing age. (2000) (0)
- 019 Ethnic differences in type 2 diabetes risk markers in children in the UK are not explained by socio-economic status: Child Heart and Health Study in England (2010) (0)
- Severe hypertriglyceridaemia with splenomegaly in type 2 diabetes (2003) (0)
- Risk of anaemia with metformin use: A MASTERMIND study (2020) (0)
- Response: Adiponectin Concentrations in Preeclampsia (2004) (0)
- Associations between low molecular weight metabolites and insulin resistance are stronger in South Asian compared with European women (2015) (0)
- Adipokines, metabolic syndrome and atherogenesis (2005) (0)
- Abstract P103: Genome-Wide Study of Gene Variants Associated with Differential Event Reduction by Pravastatin Therapy (2011) (0)
- The -2481C variant allele of the lysine acetyltransferase PCAF is associated with reduced vascular mortality. Results from three independent prospective studies (2010) (0)
- Erratum: Adiponectin and its association with bone mass accrual in childhood (2012) (0)
- MON-645 Association of Baseline Cardio-Metabolic Parameters on the Treatment Effects of Empagliflozin When Added to Metformin in Patients with T2D (2020) (0)
- Causal impact of body mass index on psoriasis 3 4 (2019) (0)
- Visit-to-visit blood pressure variability, average blood pressure and cognitive function in old age (2013) (0)
- P6517Three-year clinical outcome of patients with abnormal glucose metabolism treated with contemporary drug-eluting stents (2019) (0)
- GENETIC VARIATION IN THE SMARCA2 GENE IS ASSOCIATED WITH CARDIOVASCULAR EVENTS (2012) (0)
- ROLE OF ADULTHOOD OBESITY. RESULTS FROM THE 1946 BRITISH BIRTH COHORT STUDY (2013) (0)
- Metabolic effects of hormone replacement preparations (1996) (0)
- Inflammation, insulin resistance, and cardiovascular disease: Cause or correlate? (2008) (0)
- Mendelian randomisation study for statin treatment – Authors' reply (2015) (0)
- Overview of insulin resistance and the metabolic syndrome (2003) (0)
- Author response for "Potential contribution of haemoconcentration to changes in lipid parameters with empagliflozin in patients with type 2 diabetes mellitus – a post hoc analysis of pooled data from four phase III randomized clinical trials" (2021) (0)
- Characterisation of the metabolic syndrome in the stroke prone spontaneously hypertensive rat and the contribution of the Y chromosome (2003) (0)
- Insulin Resistance — The Metabolic Syndrome, Edited by G.M. Reaven, A. Laws. ISBN 0-896-03588-3 S/4674199 (2000) (0)
- Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes (2019) (0)
- 115 Persistence of Infarct Zone Oedema at 6 Months after Acute ST-elevation Myocardial Infarction: Incidence, Pathophysiology and Association with Left Ventricular Remodelling (2016) (0)
- Abstract 516: Urinary Proteomic Biomarkers to Predict Cardiovascular Events (2013) (0)
- Non‐alcoholic fatty liver disease: what is it, when does it occur, and why does it matter? (2007) (0)
- EPIDEMIOLOGY-RENALOUTCOMES SP 200 TABUK FORMULA : A MODIFIED CKD-EPI FORMULA IMPROVES PREDICTING GFR IN SAUDI POPULATION (2013) (0)
- Preanalytical study of fetuin-A: effect of sample type, processing speed and freeze–thaw cycles (2015) (0)
- Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels (2018) (0)
- Managing cardiovascular risk in rheumatoid patients. (2012) (0)
- The time-varying cardiovascular benefits of glucagon like peptide-1 agonist (GLP-RA)therapy in patients with type 2 diabetes mellitus: A meta-analysis of multinational randomized trials (2021) (0)
- Statins and rheumatoid arthritis - Reply (2004) (0)
- Research digest: new insights into established risk pathways. (2019) (0)
- The Relative and Combined Ability of High Sensitivity Cardiac Troponin T and N-Terminal pro-BNP to Predict Cardiovascular Events and Death in Patients with Type 2 Diabetes Mellitus (2013) (0)
- Effects and Safety of Gastric Bypass Surgery in Obese Individuals with Type 1 Diabetes: A Nationwide, Matched, Observational Cohort Study (2020) (0)
- Recorded diagnosis of NAFLD and the risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults (2019) (0)
- Statins and rheumatoid arthritis (2004) (0)
- Sattar, N. (2018). Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE (2018) (0)
- Lipoprotein profile, Low Density Lipoprotein (LDL) subtraction distribution, and hepatic lipase activity in menopausal women with supraphysiological levels of oestrogen (SEI) (1998) (0)
- The Effect of Pregnancy on Energy Metabolism, Body Composition, and Endothelial Function (2009) (0)
- Correction: Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation (2022) (0)
- Subclinical macro and microvascular disease is differently associated with depressive symptoms in men and women: Findings from the SABRE population-based study (2020) (0)
- Postprandial vascular dysfunction is associated with raised blood pressure and adverse left ventricular remodelling in adolescent adiposity Hauser: Mesenteric vasoreactivity and CV risk in teenagers (2019) (0)
- Predictors of response to SGLT2-inhibitors and DPP4-inhibitors: a MASTERMIND stratified medicine study (2017) (0)
- Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation (0)
- Macrovascular diseaseReducing cardiovascular risk in type 2 diabetes mellitus (2010) (0)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (0)
- CHARACTERIZATION OF THE BIOLOGICAL MECHANISMS OF EMPAGLIFLOZIN THROUGH LARGE-SCALE PROTEOMICS (2018) (0)
- 975-P: Adverse Muscle Composition Is Linked to a Higher Risk Type 2 Diabetes Phenotype (2021) (0)
- The Changing Landscape of Diabetes Diagnosis and Screening (2013) (0)
- Response to Effect of serum chloride on mortality in hypertensive patients. (2014) (0)
- Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors - analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies. (2021) (0)
- What role for adipocytokines in insulin resistance and diabetes prediction? From genes to epidemiology (2006) (0)
- Impact of Postprandial Lipemia and Glycemia on Inflammatory Factors in over 1000 Individuals in the US and UK: Insights from the PREDICT 1 and InterCardio Studies (2020) (0)
- 114 Persistence of Haemoglobin Degradation Products within Infarct Scar Tissue after ST-elevation Myocardial Infarction: Incidence, Correlates and Implications for Left Ventricular Remodelling (2016) (0)
- TCT CONNECT-16 Implications of Impaired Coronary Flow on the Effects of Intracoronary Alteplase During Primary Percutaneous Coronary Intervention (2020) (0)
- Diabetes management gains: teaching old dogs new tricks (2019) (0)
- ASSOCIATION OF BLOOD PRESSURE LOWERING MEDICATION WITH VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY AND COGNITIVE FUNCTION IN OLD AGE (2014) (0)
- Author Correction: Associations of social and economic and pregnancy exposures with blood pressure in UK White British and Pakistani children age 4/5 (2018) (0)
- Mullerian Inhibiting Substance is elevated in obese women with PCOS and is suppressed by metformin treatment (2004) (0)
- Syndrome Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary (2003) (0)
- The Bronchial Microbiome and Asthma Phenotypes (2013) (0)
- 16 The cardiac toxicity CMR study in patients with lung cancer treated with chemo-radiotherapy: The cart study- a semi quantitative analysis of the myocardial perfusion index (2016) (0)
- Can biomarkers help find the ‘sweet spot’ for treating patients with diabetes? (2021) (0)
- The definition of pre-diabetes influences the nature of its association with cardiovascular disease, and differs by ethnicity (2015) (0)
- Diabetes in the South Asian diaspora (2007) (0)
- Magnetic Resonance Imaging (MRI) Determined Childhood Abdominal Adiposity and its Association with Subsequent Cardiovascular Risk Factors in Adolescence: Prospective Cohort Study (2010) (0)
- Table of Contents (2020) (0)
- The potential role of statins in the treatment of rheumatoid arthritis (2005) (0)
- Change in hepatic output of palmitic acid after weight loss in type 2 diabetes (2020) (0)
- Supplementary material : Effect of Evolocumab on Lipoprotein Particles (2017) (0)
- CIRCULATING CONCENTRATIONS OF TOTAL AND FREE LEPTIN IN GASTROINTESTINAL CANCER PATIENTS AND THE EFFECT OF MEGESTEROL ACETATE (2001) (0)
- Pathophysiology of Remission in Type 2 Diabetes—The Diabetes Remission Clinical Trial (DiRECT) (2018) (0)
- Dissociation of cardiac remodelling and aortic stiffness indices as of cardiac/vascular risk, and their relationship to vitamin D3 (2011) (0)
- Research digest: updates on diabetes in pregnancy. (2018) (0)
- P697Assessing the causal role of adiposity on early markers of cardiovascular disease: increases in blood pressure, but not metabolic risk factors, are related to arterial stiffness in young adults (2017) (0)
- Edinburgh Research Explorer Secretory Phospholipase A2-IIA and Cardiovascular Disease (2018) (0)
- In-hospital Cardiac Arrest in Patients With Heart Failure: Long- and Short-term Survival and Trends (2021) (0)
- COGNITIVE AND KIDNEY FUNCTION AT AGE 60-64 YEARS: RESULTS FROM THE 1946 BRITISH BIRTH COHORT STUDY (2013) (0)
- Statins for primary and secondary prevention of vascular disease in the elderly : estimation of individual absolute treatment effects (2016) (0)
- Associations of social and economic and pregnancy exposures with blood pressure in UK White British and Pakistani children age 4/5 (2018) (0)
- Development of an online risk calculator to predict durability of good glycaemic control with sulfonylurea and thiazolidinedione therapy: a MASTERMIND stratified medicine study (2017) (0)
- Associations of targeted circulating microRNAs with insulin resistance in the CAMERA (Carotid Atherosclerosis: MEtformin for insulin ResistAnce) trial (2019) (0)
- Authors’ reply to McKenna-Barry and Ryan (2019) (0)
- Circulating alanine aminotransferase (ALT) is elevated in obese women with PCOS, and is reduced by protracted metformin treatment (2005) (0)
- Title : Genetic evidence for a link between favorable adiposity and lower risk of type 2 diabetes , hypertension and heart disease . Short running title : Favorable adiposity and lower cardiometabolic risk Author list : (2016) (0)
- Response to: ‘The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis’ by González-Gay et al (2014) (0)
- STEPWISE APPROACH TO LIPID LOWERING IN ‘VERY HIGH RISK’ PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY: A MONTE CARLO SIMULATION (2022) (0)
- The role of the metabolic profile in mediating the relationship between body mass index and left ventricular mass in adolescents: analysis of a prospective cohort study (2020) (0)
- Noncustomised Birth Weight Centiles and Prediction of Stillbirth and Infant Mortality and Morbidity: A Cohort Study of 979,912 Term Singleton Pregnancies (2017) (0)
- Research digest: new horizons in heart failure therapy. (2019) (0)
- Poster session 3 (2012) (0)
- Risk of anaemia with metformin use in type 2 diabetes: A MASTERMIND study Short title: Risk of anaemia with metformin use (2021) (0)
- Up front (2016) (0)
- Research digest: CV trials in diabetes-looking ahead. (2018) (0)
- Widespread use of fibrates in type 2 diabetes is not supported by the evidence (2017) (0)
- Maternal docosahexaenoic acid is vital for closure of the neural tube: A prospective, observational study of human pregnancy (2017) (0)
- Non-invasive liver tests in electronic health records of patients with non-alcoholic fatty liver disease: combined analysis from four European countries (2018) (0)
- Type Short report Title Walking and Inflammatory Markers in Individuals Screened for Type 2 Diabetes (2017) (0)
- Women with cardiac syndrome X exhibit features of the insulin resistance syndrome and impaired peripheral microvascular function (2003) (0)
- Plenary Session 3 : Key Essential Nutrients 653 Zinc and selenium – changing farming practices to improve the food supply (0)
- Commentary: Documenting ethnic variations in vascular risk: where do we go from here? (2003) (0)
- HORMONE REPLACEMENT THERAPY AND C-REACTIVE PROTEIN. AUTHORS' REPLY (1999) (0)
- OP91 Assessing causal links between smoking and regional adiposity using a Mendelian randomisation approach (2014) (0)
- The Effect of HRT on Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus (1999) (0)
- Correction to: Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register (2019) (0)
- Ceramides: a new player in the inflammation-insulin resistance paradigm? (2010) (0)
- Faculty Opinions recommendation of Health-related quality of life association with weight change in type 2 diabetes mellitus: perception vs. reality. (2014) (0)
- Diabetes Remission Clinical Trial (DiRECT)—Changes in Hepatic VLDL1-TG Production and Intrapancreatic Fat during Weight Maintenance Phase (2018) (0)
- Biomarker Research in Glucose Disorders: Current Concepts and Clinical Applications (2013) (0)
- INITIATION OF SGLT-2 INHIBITORS AND GLP1 RECEPTOR AGONISTS ACCORDING TO FRAILTY IN PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE- A DANISH NATIONWIDE COHORT STUDY (2023) (0)
- ABC of Obesity (1st edition) (2007) (0)
- Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years (2017) (0)
- [LB.03.08] SERUM CHLORIDE AND ADVERSE CARDIOVASCULAR EVENTS IN THE ANGLO SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT) (2017) (0)
- Up front April 2016 (2016) (0)
- Erratum (2015) (0)
- THE EFFECT OF METFORMIN ON THE LIPOPROTEIN PROFILE AND LIPOPROTEIN PARTICLE SIZE IN THE CAROTID ATHEROSCLEROSIS: METFORMIN FOR INSULIN RESISTANCE (CAMERA) TRIAL (2015) (0)
- Myocardial haemorrhage after acute reperfused ST-elevation myocardial infarction evolves progressively and contributes to the early bimodal pattern in T2-relaxation time: advanced imaging and clinical significance (2016) (0)
- Da Qing 30 years on: more reasons to extend diabetes prevention. (2019) (0)
- Statins and risk of incident diabetes Reply (2010) (0)
- Noval miRNA biomarkers in cardiometabolic disease: Data from the carotid atherosclerosis metformin for insulin resistance (CAMERA) trial (2019) (0)
- 1 Assessing the causal role of body mass index on cardiovascular health in young adults : 1 Mendelian randomization and recall-by-genotype analyses 2 (2017) (0)
- PO-0667: Cardiac toxicity in lung cancer patients after chemo-radiotherapy (CART): a pilot study (2015) (0)
- Response to: ‘On the approach for determining association between changes in marital quality and cardiovascular disease risk factors’ by MM Pike (2018) (0)
- THE PRESENT AND FUTURE STATE-OFTHE - (0)
- Research digest: NAFLD in the spotlight. (2016) (0)
- OP0165 Changes in Lipoprotein(A) after Treatment with Tocilizumab (TCZ), Adalimumab (ADA), and Methotrexate (MTX) in Patients with Rheumatoid Arthritis (RA) (2014) (0)
- Epidemiology - renal outcomes (2013) (0)
- Statins in the Era of Evidence-Based Medicine — Who Will Not “Prosper”? (2003) (0)
- University of Groningen A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function Porcu, (2013) (0)
- Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes (2022) (0)
- Comment on: Letter to the Editor from Payet, Pereira, Soubrier, and Mathieu (2012) (0)
- Obesity and its associations with cardiometabolic outcomes: Understanding the bigger picture (2014) (0)
- Suppression of in vitro and in vivo parameters of inflammatory synovitis by simvastatin (2002) (0)
- Maternal obesity and ethnic groups: trends in 552,303 births over 13 years in England, UK (2010) (0)
- Impact of type 2 diabetes on life expectancy and cause-specific mortality in White, South Asian and Black patients. (2016) (0)
- Lipoprotein(a) testing experience in a specialist lipid clinic in scotland suggests a need to more commonly measure (2018) (0)
- IMPACT OF EVOLOCUMAB THERAPY IN PATIENTS WITH DISCORDANCE BETWEEN LDL-C AND LDL-P (2017) (0)
- Research digest: prediabetes definitions and diabetes prevention. (2017) (0)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2019) (0)
- Are Statins Effective in High-Risk Primary Prevention?—Reply (2010) (0)
- Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland. (2018) (0)
- Iconography : Effect of Evolocumab on Lipoprotein Particles (2017) (0)
- Drug Prescription Based on Predicted Treatment Responsiveness: An Application to the PROSPER Randomised Controlled Trial (2022) (0)
- Faculty Opinions recommendation of Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance. (2014) (0)
- 432 Investigating a causal relationship between body mass index and inflammatory skin disease using mendelian randomisation (2018) (0)
- T7.4 Increased activated macrophages and inflammatory adipokines from adipose tissue in pre-eclampsisa (2010) (0)
- Diagnosis of non-alcoholic fatty liver disease and its stages (2011) (0)
- Weight gain from birth to five years is associated with greater muscle strength, lean mass and insulin sensitivity, while gain from five to seven years is associated with greater fat mass and insulin resistance in young adults (2017) (0)
- Urinary proteomics can be predictive of cardiovascular events (2013) (0)
- University of Birmingham Identifying cases of type 2 diabetes in heterogeneous data sources (2016) (0)
- Weight loss, visit-to-visit body weight variability and cognitive function in a cohort of older people with or at risk of atherosclerotic cardiovascular disease (2022) (0)
- Cardio-metabolic consequences of PCOS (2005) (0)
- Macrovascular Disease in Type 2 Diabetes (2021) (0)
- Faculty Opinions recommendation of Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (2014) (0)
- OP19 Fruit, vegetable, vitamin C intakes and plasma vitamin C: associations with insulin resistance in UK primary school children (2014) (0)
- Using human genetics to understand the causes and consequences of circulating cardiac troponin I in the general population (2020) (0)
- Cardiovascular disease in rheumatoid arthritis (2004) (0)
- Explorer Type 2 diabetes , socioeconomic status and life expectancy in Scotland ( 2012 – 2014 ) : population-based observational study (2018) (0)
- "The Times They Are A-Changin'" at Diabetes Care. (2022) (0)
- A calculator to predict durability of HbA(1c) response with DPP4 inhibitors, sulfonylureas and thiazolidinediones: a MASTERMIND precision medicine study (2017) (0)
- FRI0134 Interleukin-6 Blockade Raises LDL via Reduced Catabolism Rather than via Increased Synthesis – A Cytokine-Specific Mechanism for Cholesterol Changes in Rheumatoid Arthritis (2016) (0)
- Authors’ reply to: Statin therapy as the fundamental therapy for cardiovascular prevention: be careful (2009) (0)
- Serum lipids in pigeon fanciers' hypersensitivity pneumonitis: A place for statins? (2005) (0)
- 2016 Usefulness of C-reactive protein in detecting higher risk patterns of myocardial infarction defined by contrast enhanced magnetic resonance imaging (2008) (0)
- 312-OR: Gender-Specific Effects on Hepatic Fat Metabolism in Type 2 Diabetes before and after Remission (2020) (0)
- Plasma tissue plasminogen activator is higher in South Asians versus Europeans and associated with the insulin resistance syndrome in both ethnic groups (2001) (0)
- OP80 Birth weight and emerging type 2 diabetes risk in UK children of South Asian, black African-Caribbean and white European origin – Child Heart and Health Study in England (CHASE) (2014) (0)
- Risk of anaemia with long-term metformin use in a community setting (2017) (0)
- Prediction scores to identify older adults at high risk for type 2 diabetes (2009) (0)
- No genetic determinants of differential cardiovascular event reduction by pravastatin in the PROSPER/PHASE study (2013) (0)
This paper list is powered by the following services:
Other Resources About Naveed Sattar
What Schools Are Affiliated With Naveed Sattar?
Naveed Sattar is affiliated with the following schools:
